[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40954422\", \"sentence_id\": 6, \"text\": \"Podcast Video (MP4 172565 KB).\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDX2ZmdWgMP5QPkSBRDMkY7uhj", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40954422\",\n      \"sentence_id\": 6,\n      \"entities\": []\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 110, "completion_tokens": 429, "total_tokens": 539, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 384, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40954422", "sentence_id": 6, "text": "Podcast Video (MP4 172565 KB)."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41173779\", \"sentence_id\": 11, \"text\": \"Our analyses are retrospective and limited by small subgroup sizes.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDdexEOdGflxZch3aO00VpzfIk", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41173779\",\n      \"sentence_id\": 11,\n      \"entities\": []\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 110, "completion_tokens": 557, "total_tokens": 667, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 512, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41173779", "sentence_id": 11, "text": "Our analyses are retrospective and limited by small subgroup sizes."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40906325\", \"sentence_id\": 4, \"text\": \"Sixteen patients were enrolled across 4 dose levels.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8ND1mfXeofVN6AGPJTgIRrjS0qP", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40906325\",\n      \"sentence_id\": 4,\n      \"entities\": []\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 110, "completion_tokens": 557, "total_tokens": 667, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 512, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40906325", "sentence_id": 4, "text": "Sixteen patients were enrolled across 4 dose levels."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 5, \"text\": \"From the perspectives of U.S.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDdSJ615SfWkSfXsBOW58MF8kh", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40873813\",\n      \"sentence_id\": 5,\n      \"entities\": []\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 106, "completion_tokens": 494, "total_tokens": 600, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 448, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40873813", "sentence_id": 5, "text": "From the perspectives of U.S."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41219112\", \"sentence_id\": 8, \"text\": \"However, some questions remain regarding patient selection and treatment sequencing.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDFpbsqZ07KQP5Mzmz7b0gRfTv", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41219112\",\n      \"sentence_id\": 8,\n      \"entities\": []\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 111, "completion_tokens": 493, "total_tokens": 604, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 448, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41219112", "sentence_id": 8, "text": "However, some questions remain regarding patient selection and treatment sequencing."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 11, \"text\": \"and $40,334 in China).\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NIGWWs566VkIvnHKBRiDkZ1lWt", "object": "chat.completion", "created": 1763443020, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40873813\",\n      \"sentence_id\": 11,\n      \"entities\": []\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 108, "completion_tokens": 365, "total_tokens": 473, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 320, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40873813", "sentence_id": 11, "text": "and $40,334 in China)."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 8, \"text\": \"Price reduction analysis provided an evidence-based basis for drug pricing and health insurance negotiations by quantifying the impact of price adjustments on economics.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDmCC7wzILNvCA46prmloT1wcv", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40873813\",\n      \"sentence_id\": 8,\n      \"entities\": []\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 125, "completion_tokens": 1133, "total_tokens": 1258, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 1088, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40873813", "sentence_id": 8, "text": "Price reduction analysis provided an evidence-based basis for drug pricing and health insurance negotiations by quantifying the impact of price adjustments on economics."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 14, \"text\": \"remained unaffordable even with an 80% price reduction.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NMao5AfhoskqbhOTae5Z1UYkLD", "object": "chat.completion", "created": 1763443024, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40873813\",\n      \"sentence_id\": 14,\n      \"entities\": []\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 113, "completion_tokens": 429, "total_tokens": 542, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 384, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40873813", "sentence_id": 14, "text": "remained unaffordable even with an 80% price reduction."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 13, \"text\": \"Price adjustment scenarios showed that China needed a 34.5% price reduction to achieve affordability, whereas the U.S.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NMrmAkHxGvnOpg9lJZEKerJylq", "object": "chat.completion", "created": 1763443024, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40873813\",\n      \"sentence_id\": 13,\n      \"entities\": []\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 123, "completion_tokens": 558, "total_tokens": 681, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 512, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40873813", "sentence_id": 13, "text": "Price adjustment scenarios showed that China needed a 34.5% price reduction to achieve affordability, whereas the U.S."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 16, \"text\": \"or China.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NOxxBBE7RmzurWBdOKe7Fhy4dp", "object": "chat.completion", "created": 1763443026, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40873813\",\n      \"sentence_id\": 16,\n      \"entities\": []\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 102, "completion_tokens": 493, "total_tokens": 595, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 448, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40873813", "sentence_id": 16, "text": "or China."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 3, \"text\": \"DESIGN: A Markov model-based cost-effectiveness analysis.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8ND0D8ZM2887LThgrhmhqKUSNbL", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40873813\",\n      \"sentence_id\": 3,\n      \"entities\": [\n        {\n          \"text\": \"Markov model\",\n          \"class\": \"Model\",\n          \"start\": 10,\n          \"end\": 22,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 112, "completion_tokens": 2329, "total_tokens": 2441, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 2240, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40873813", "sentence_id": 3, "text": "DESIGN: A Markov model-based cost-effectiveness analysis."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 17, \"text\": \"The study supports differentiated pricing strategies to balance clinical benefits with the rational allocation of healthcare resources.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NQEUx4uOaiODQz40vd7dP9rytz", "object": "chat.completion", "created": 1763443028, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40873813\",\n      \"sentence_id\": 17,\n      \"entities\": []\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 117, "completion_tokens": 813, "total_tokens": 930, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 768, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40873813", "sentence_id": 17, "text": "The study supports differentiated pricing strategies to balance clinical benefits with the rational allocation of healthcare resources."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40906325\", \"sentence_id\": 0, \"text\": \"As monotherapy, PARP inhibitors have little cytotoxic effect in tumors without homologous recombinant repair (HRR) alterations.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDwjmR95DDTgTpuJFr81vXIWGU", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40906325\",\n      \"sentence_id\": 0,\n      \"entities\": [\n        {\n          \"text\": \"PARP inhibitors\",\n          \"class\": \"Chemical\",\n          \"start\": 16,\n          \"end\": 31,\n          \"ids\": []\n        },\n        {\n          \"text\": \"HRR\",\n          \"class\": \"Pathway\",\n          \"start\": 108,\n          \"end\": 111,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 124, "completion_tokens": 2110, "total_tokens": 2234, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 1984, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40906325", "sentence_id": 0, "text": "As monotherapy, PARP inhibitors have little cytotoxic effect in tumors without homologous recombinant repair (HRR) alterations."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40906325\", \"sentence_id\": 6, \"text\": \"In phase 1b, one patient receiving talazoparib 1\u00a0mg and temozolomide 75\u00a0mg/m\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDBAPd8h2QvQlf1b9WynyL0pIJ", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40906325\",\n      \"sentence_id\": 6,\n      \"entities\": [\n        {\n          \"text\": \"talazoparib\",\n          \"class\": \"Chemical\",\n          \"start\": 35,\n          \"end\": 45,\n          \"ids\": []\n        },\n        {\n          \"text\": \"temozolomide\",\n          \"class\": \"Chemical\",\n          \"start\": 56,\n          \"end\": 67,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 129, "completion_tokens": 1921, "total_tokens": 2050, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 1792, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40906325", "sentence_id": 6, "text": "In phase 1b, one patient receiving talazoparib 1\u00a0mg and temozolomide 75\u00a0mg/m"}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41186828\", \"sentence_id\": 1, \"text\": \"However, the acquired or de novo PARP inhibitor resistance limits treatment success.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDltse2PyhEeQxXVqcmrloqwvi", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41186828\",\n      \"sentence_id\": 1,\n      \"entities\": [\n        {\n          \"text\": \"PARP inhibitor\",\n          \"class\": \"Chemical\",\n          \"start\": 33,\n          \"end\": 47,\n          \"ids\": []\n        },\n        {\n          \"text\": \"resistance\",\n          \"class\": \"Phenotype\",\n          \"start\": 48,\n          \"end\": 58,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 114, "completion_tokens": 2621, "total_tokens": 2735, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 2496, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41186828", "sentence_id": 1, "text": "However, the acquired or de novo PARP inhibitor resistance limits treatment success."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41216708\", \"sentence_id\": 8, \"text\": \"Mechanisms of synergism targeted homologous recombination repair, DNA replication, and apoptosis regulation.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDIqalcmUdVToYfK1rlO00fJBH", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41216708\",\n      \"sentence_id\": 8,\n      \"entities\": [\n        {\n          \"text\": \"homologous recombination repair\",\n          \"class\": \"Pathway\",\n          \"start\": 33,\n          \"end\": 64,\n          \"ids\": []\n        },\n        {\n          \"text\": \"DNA replication\",\n          \"class\": \"Pathway\",\n          \"start\": 66,\n          \"end\": 80,\n          \"ids\": []\n        },\n        {\n          \"text\": \"apoptosis regulation\",\n          \"class\": \"Pathway\",\n          \"start\": 83,\n          \"end\": 107,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 118, "completion_tokens": 2730, "total_tokens": 2848, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 2560, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41216708", "sentence_id": 8, "text": "Mechanisms of synergism targeted homologous recombination repair, DNA replication, and apoptosis regulation."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41077155\", \"sentence_id\": 1, \"text\": \"Understanding the interactions between Pgp and its substrates is therefore crucial for optimal drug design and ultimately clinical success.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDdbF3i7AQZmc6wMsVi7NdDRK3", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41077155\",\n      \"sentence_id\": 1,\n      \"entities\": [\n        {\n          \"text\": \"Pgp\",\n          \"class\": \"Gene\",\n          \"start\": 39,\n          \"end\": 42,\n          \"ids\": [\"ABCB1\"]\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 120, "completion_tokens": 2331, "total_tokens": 2451, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 2240, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41077155", "sentence_id": 1, "text": "Understanding the interactions between Pgp and its substrates is therefore crucial for optimal drug design and ultimately clinical success."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40954422\", \"sentence_id\": 5, \"text\": \"Podcast and Infographic are available for this article.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDO3BbqXVCRfvLhWrte53rET3V", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40954422\",\n      \"sentence_id\": 5,\n      \"entities\": [\n        {\n          \"text\": \"this article\",\n          \"class\": \"Paper\",\n          \"start\": 42,\n          \"end\": 54,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 109, "completion_tokens": 2069, "total_tokens": 2178, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 1984, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40954422", "sentence_id": 5, "text": "Podcast and Infographic are available for this article."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41216708\", \"sentence_id\": 3, \"text\": \"To identify the most suitable PARPi for UC, we compared Olaparib with Talazoparib.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDg5l5CsJ6kYtrWisTuWNtN2Zd", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41216708\",\n      \"sentence_id\": 3,\n      \"entities\": [\n        {\n          \"text\": \"PARPi\",\n          \"class\": \"Chemical\",\n          \"start\": 30,\n          \"end\": 35,\n          \"ids\": []\n        },\n        {\n          \"text\": \"UC\",\n          \"class\": \"Disease\",\n          \"start\": 40,\n          \"end\": 42,\n          \"ids\": []\n        },\n        {\n          \"text\": \"Olaparib\",\n          \"class\": \"Chemical\",\n          \"start\": 56,\n          \"end\": 64,\n          \"ids\": []\n        },\n        {\n          \"text\": \"Talazoparib\",\n          \"class\": \"Chemical\",\n          \"start\": 70,\n          \"end\": 81,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 121, "completion_tokens": 2891, "total_tokens": 3012, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 2688, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41216708", "sentence_id": 3, "text": "To identify the most suitable PARPi for UC, we compared Olaparib with Talazoparib."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41173779\", \"sentence_id\": 5, \"text\": \"Objective response rates (ORRs) and median overall survival (OS) with 95% confidence intervals (Clopper-Pearson method) and p values (two-sided Fisher's exact test) were calculated.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDOtxqiTUm3CwLHtf8CB76nbvZ", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41173779\",\n      \"sentence_id\": 5,\n      \"entities\": [\n        {\n          \"text\": \"Objective response rates\",\n          \"class\": \"Finding\",\n          \"start\": 0,\n          \"end\": 23,\n          \"ids\": []\n        },\n        {\n          \"text\": \"median overall survival\",\n          \"class\": \"Phenotype\",\n          \"start\": 36,\n          \"end\": 57,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 141, "completion_tokens": 3262, "total_tokens": 3403, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 3136, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41173779", "sentence_id": 5, "text": "Objective response rates (ORRs) and median overall survival (OS) with 95% confidence intervals (Clopper-Pearson method) and p values (two-sided Fisher's exact test) were calculated."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40906325\", \"sentence_id\": 5, \"text\": \"The most common adverse events were thrombocytopenia, neutropenia, anemia, fatigue, and nausea.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8ND2yZ5inU4jFBODQZvwyQ0Ac6A", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40906325\",\n      \"sentence_id\": 5,\n      \"entities\": [\n        {\n          \"text\": \"thrombocytopenia\",\n          \"class\": \"Finding\",\n          \"start\": 36,\n          \"end\": 52,\n          \"ids\": []\n        },\n        {\n          \"text\": \"neutropenia\",\n          \"class\": \"Finding\",\n          \"start\": 54,\n          \"end\": 65,\n          \"ids\": []\n        },\n        {\n          \"text\": \"anemia\",\n          \"class\": \"Finding\",\n          \"start\": 67,\n          \"end\": 73,\n          \"ids\": []\n        },\n        {\n          \"text\": \"fatigue\",\n          \"class\": \"Finding\",\n          \"start\": 75,\n          \"end\": 82,\n          \"ids\": []\n        },\n        {\n          \"text\": \"nausea\",\n          \"class\": \"Finding\",\n          \"start\": 88,\n          \"end\": 93,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 121, "completion_tokens": 2356, "total_tokens": 2477, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 2112, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40906325", "sentence_id": 5, "text": "The most common adverse events were thrombocytopenia, neutropenia, anemia, fatigue, and nausea."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41216708\", \"sentence_id\": 6, \"text\": \"We investigated a new combination treatment using PLX51107, an epigenetic BET protein inhibitor, to increase PARPi efficacy.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDfCyKXiBEr0nZdxpkmxD7wCcB", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41216708\",\n      \"sentence_id\": 6,\n      \"entities\": [\n        {\n          \"text\": \"PLX51107\",\n          \"class\": \"Chemical\",\n          \"start\": 50,\n          \"end\": 58,\n          \"ids\": []\n        },\n        {\n          \"text\": \"PARPi\",\n          \"class\": \"Chemical\",\n          \"start\": 109,\n          \"end\": 114,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 125, "completion_tokens": 2557, "total_tokens": 2682, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 2432, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41216708", "sentence_id": 6, "text": "We investigated a new combination treatment using PLX51107, an epigenetic BET protein inhibitor, to increase PARPi efficacy."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 7, \"text\": \"One-way sensitivity analysis and probabilistic sensitivity analysis were used to validate the robustness of the model.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDzrtlRXZd0gatlySnO4sYsFUC", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40873813\",\n      \"sentence_id\": 7,\n      \"entities\": [\n        {\n          \"text\": \"model\",\n          \"class\": \"Model\",\n          \"start\": 108,\n          \"end\": 113,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 118, "completion_tokens": 2390, "total_tokens": 2508, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 2304, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40873813", "sentence_id": 7, "text": "One-way sensitivity analysis and probabilistic sensitivity analysis were used to validate the robustness of the model."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41216708\", \"sentence_id\": 1, \"text\": \"Clinical trials with PARP inhibitors (PARPi), particularly in Cisplatin-treated UC, yielded limited response.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDkHoqxE3rndgFgTLsduGQxsHq", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41216708\",\n      \"sentence_id\": 1,\n      \"entities\": [\n        {\n          \"text\": \"PARP inhibitors\",\n          \"class\": \"Chemical\",\n          \"start\": 21,\n          \"end\": 36,\n          \"ids\": []\n        },\n        {\n          \"text\": \"PARPi\",\n          \"class\": \"Chemical\",\n          \"start\": 38,\n          \"end\": 43,\n          \"ids\": []\n        },\n        {\n          \"text\": \"Cisplatin\",\n          \"class\": \"Chemical\",\n          \"start\": 62,\n          \"end\": 71,\n          \"ids\": []\n        },\n        {\n          \"text\": \"UC\",\n          \"class\": \"Disease\",\n          \"start\": 80,\n          \"end\": 82,\n          \"ids\": []\n        },\n        {\n          \"text\": \"response\",\n          \"class\": \"Finding\",\n          \"start\": 100,\n          \"end\": 108,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 121, "completion_tokens": 3632, "total_tokens": 3753, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 3392, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41216708", "sentence_id": 1, "text": "Clinical trials with PARP inhibitors (PARPi), particularly in Cisplatin-treated UC, yielded limited response."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41158759\", \"sentence_id\": 0, \"text\": \"Despite advances in cancer treatment with targeted therapies and immunotherapies, triple-negative breast cancer (TNBC) has not significantly benefited from these developments.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDcBSqnSPjf6ua1j8Bm36paE7R", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41158759\",\n      \"sentence_id\": 0,\n      \"entities\": [\n        {\n          \"text\": \"triple-negative breast cancer (TNBC)\",\n          \"class\": \"Disease\",\n          \"start\": 82,\n          \"end\": 118,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 128, "completion_tokens": 3163, "total_tokens": 3291, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 3072, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41158759", "sentence_id": 0, "text": "Despite advances in cancer treatment with targeted therapies and immunotherapies, triple-negative breast cancer (TNBC) has not significantly benefited from these developments."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40874518\", \"sentence_id\": 0, \"text\": \"Pancreatic ductal adenocarcinoma (PDAC) is a highly fatal disease with limited treatment options.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8ND1zuiemhwqZXhcKPOYOPMkj01", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40874518\",\n      \"sentence_id\": 0,\n      \"entities\": [\n        {\n          \"text\": \"Pancreatic ductal adenocarcinoma (PDAC)\",\n          \"class\": \"Disease\",\n          \"start\": 0,\n          \"end\": 38,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 122, "completion_tokens": 3103, "total_tokens": 3225, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 3008, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40874518", "sentence_id": 0, "text": "Pancreatic ductal adenocarcinoma (PDAC) is a highly fatal disease with limited treatment options."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41219112\", \"sentence_id\": 3, \"text\": \"METHODS: We reviewed the literature on PARPi treatment for CRPC and provide a narrative synthesis of the evidence for the rapidly evolving treatment landscape in this setting.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDKWTuaKu5c7fKQOb17bMMvAxr", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41219112\",\n      \"sentence_id\": 3,\n      \"entities\": [\n        {\n          \"text\": \"PARPi\",\n          \"class\": \"Chemical\",\n          \"start\": 39,\n          \"end\": 44,\n          \"ids\": []\n        },\n        {\n          \"text\": \"CRPC\",\n          \"class\": \"Disease\",\n          \"start\": 59,\n          \"end\": 63,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 131, "completion_tokens": 2748, "total_tokens": 2879, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 2624, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41219112", "sentence_id": 3, "text": "METHODS: We reviewed the literature on PARPi treatment for CRPC and provide a narrative synthesis of the evidence for the rapidly evolving treatment landscape in this setting."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41186828\", \"sentence_id\": 10, \"text\": \"However, further preclinical and clinical investigations should be required to elucidate the underlying molecular mechanisms behind ATRi and PARPi interactions in TNBC cells.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDsfPxNYohrnOPwDu6kCJ9Rjqh", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41186828\",\n      \"sentence_id\": 10,\n      \"entities\": [\n        {\n          \"text\": \"ATRi\",\n          \"class\": \"Chemical\",\n          \"start\": 132,\n          \"end\": 136,\n          \"ids\": []\n        },\n        {\n          \"text\": \"PARPi\",\n          \"class\": \"Chemical\",\n          \"start\": 140,\n          \"end\": 145,\n          \"ids\": []\n        },\n        {\n          \"text\": \"TNBC\",\n          \"class\": \"Disease\",\n          \"start\": 162,\n          \"end\": 166,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 129, "completion_tokens": 2723, "total_tokens": 2852, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 2560, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41186828", "sentence_id": 10, "text": "However, further preclinical and clinical investigations should be required to elucidate the underlying molecular mechanisms behind ATRi and PARPi interactions in TNBC cells."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40874518\", \"sentence_id\": 10, \"text\": \"Further research is needed to validate these findings and explore novel therapeutic strategies to overcome resistance to PARPi in PDAC.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDGrfL3lqzkMQ6BaMgfrz7ZqeE", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40874518\",\n      \"sentence_id\": 10,\n      \"entities\": [\n        {\n          \"text\": \"findings\",\n          \"class\": \"Finding\",\n          \"start\": 45,\n          \"end\": 53,\n          \"ids\": []\n        },\n        {\n          \"text\": \"PARPi\",\n          \"class\": \"Chemical\",\n          \"start\": 121,\n          \"end\": 126,\n          \"ids\": []\n        },\n        {\n          \"text\": \"PDAC\",\n          \"class\": \"Disease\",\n          \"start\": 130,\n          \"end\": 134,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 122, "completion_tokens": 3169, "total_tokens": 3291, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 3008, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40874518", "sentence_id": 10, "text": "Further research is needed to validate these findings and explore novel therapeutic strategies to overcome resistance to PARPi in PDAC."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41077155\", \"sentence_id\": 9, \"text\": \"Overall, our results provide insight for future potential development of PARPi that are less subject to Pgp-mediated transport.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDMPjRjCaYVRtcKwDELZLRIW2B", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41077155\",\n      \"sentence_id\": 9,\n      \"entities\": [\n        {\n          \"text\": \"PARPi\",\n          \"class\": \"Chemical\",\n          \"start\": 72,\n          \"end\": 77,\n          \"ids\": []\n        },\n        {\n          \"text\": \"Pgp\",\n          \"class\": \"Gene\",\n          \"start\": 103,\n          \"end\": 106,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 122, "completion_tokens": 2555, "total_tokens": 2677, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 2432, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41077155", "sentence_id": 9, "text": "Overall, our results provide insight for future potential development of PARPi that are less subject to Pgp-mediated transport."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41077155\", \"sentence_id\": 7, \"text\": \"Saturation transfer double difference (STDD) NMR revealed the PARPi structural basis for Pgp binding.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDUiST4XPMntRAcMzloTPlv2OE", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41077155\",\n      \"sentence_id\": 7,\n      \"entities\": [\n        {\n          \"text\": \"PARPi\",\n          \"class\": \"Chemical\",\n          \"start\": 62,\n          \"end\": 67,\n          \"ids\": []\n        },\n        {\n          \"text\": \"Pgp\",\n          \"class\": \"Gene\",\n          \"start\": 89,\n          \"end\": 92,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 121, "completion_tokens": 3453, "total_tokens": 3574, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 3328, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41077155", "sentence_id": 7, "text": "Saturation transfer double difference (STDD) NMR revealed the PARPi structural basis for Pgp binding."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683290\", \"sentence_id\": 4, \"text\": \"In the genetically unselected cohort, patients were randomly assigned from 200 centres, including hospitals, cancer centres, and medical centres, in 26 countries in North America, Europe, Israel, South America, South Africa, and the Asia-Pacific region.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NbK73RU6ybY8yxLEhqZHm23FqX", "object": "chat.completion", "created": 1763443039, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40683290\",\n      \"sentence_id\": 4,\n      \"entities\": []\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 149, "completion_tokens": 557, "total_tokens": 706, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 512, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40683290", "sentence_id": 4, "text": "In the genetically unselected cohort, patients were randomly assigned from 200 centres, including hospitals, cancer centres, and medical centres, in 26 countries in North America, Europe, Israel, South America, South Africa, and the Asia-Pacific region."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41049440\", \"sentence_id\": 5, \"text\": \"Single-cell RNA-sequencing data and the Human Protein Atlas showed ORMDL2 enrichment in tumor stromal cells.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDQvzRopwuvk0HhS3rlPOO6ebQ", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41049440\",\n      \"sentence_id\": 5,\n      \"entities\": [\n        {\n          \"text\": \"ORMDL2\",\n          \"class\": \"Gene\",\n          \"start\": 67,\n          \"end\": 73,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 123, "completion_tokens": 2582, "total_tokens": 2705, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 2496, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41049440", "sentence_id": 5, "text": "Single-cell RNA-sequencing data and the Human Protein Atlas showed ORMDL2 enrichment in tumor stromal cells."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 12, \"text\": \"Sensitivity analyses showed that the utility of PFS and drug prices impacted the results most.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NJjksqzeDk3h5ROA30AVWadH5q", "object": "chat.completion", "created": 1763443021, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40873813\",\n      \"sentence_id\": 12,\n      \"entities\": [\n        {\n          \"text\": \"PFS\",\n          \"class\": \"Phenotype\",\n          \"start\": 48,\n          \"end\": 51,\n          \"ids\": []\n        },\n        {\n          \"text\": \"drug\",\n          \"class\": \"Chemical\",\n          \"start\": 56,\n          \"end\": 60,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 116, "completion_tokens": 3579, "total_tokens": 3695, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 3456, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40873813", "sentence_id": 12, "text": "Sensitivity analyses showed that the utility of PFS and drug prices impacted the results most."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41216708\", \"sentence_id\": 0, \"text\": \"Advanced urothelial carcinoma (UC) requires new therapeutics beyond chemo- and immunotherapies.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDwcIJ28Tomjwb6nC61L3UeWdA", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41216708\",\n      \"sentence_id\": 0,\n      \"entities\": [\n        {\n          \"text\": \"urothelial carcinoma\",\n          \"class\": \"Disease\",\n          \"start\": 9,\n          \"end\": 28,\n          \"ids\": []\n        },\n        {\n          \"text\": \"UC\",\n          \"class\": \"Disease\",\n          \"start\": 31,\n          \"end\": 32,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 119, "completion_tokens": 3132, "total_tokens": 3251, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 3008, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41216708", "sentence_id": 0, "text": "Advanced urothelial carcinoma (UC) requires new therapeutics beyond chemo- and immunotherapies."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40874518\", \"sentence_id\": 8, \"text\": \"Our study highlights the complexity of resistance mechanisms to PARPi in PDAC and identifies potential therapeutic targets in metabolism.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDe7CORZx4ujHzq47w99IhbOWF", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40874518\",\n      \"sentence_id\": 8,\n      \"entities\": [\n        {\"text\": \"resistance\", \"class\": \"Phenotype\", \"start\": 39, \"end\": 49, \"ids\": []},\n        {\"text\": \"PARPi\", \"class\": \"Chemical\", \"start\": 64, \"end\": 69, \"ids\": []},\n        {\"text\": \"PDAC\", \"class\": \"Disease\", \"start\": 73, \"end\": 77, \"ids\": []},\n        {\"text\": \"metabolism\", \"class\": \"Pathway\", \"start\": 126, \"end\": 136, \"ids\": []}\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 121, "completion_tokens": 3439, "total_tokens": 3560, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 3264, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40874518", "sentence_id": 8, "text": "Our study highlights the complexity of resistance mechanisms to PARPi in PDAC and identifies potential therapeutic targets in metabolism."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41049440\", \"sentence_id\": 7, \"text\": \"Collectively, our findings establish ORMDL2 as a multi-functional macromolecular regulator of immune suppression and therapeutic resistance in GBM, providing new mechanistic insights and potential targets for translational medicines.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8ND45coX2nxbAI34bDb0k0GQgOI", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41049440\",\n      \"sentence_id\": 7,\n      \"entities\": [\n        {\n          \"text\": \"findings\",\n          \"class\": \"Finding\",\n          \"start\": 18,\n          \"end\": 26,\n          \"ids\": []\n        },\n        {\n          \"text\": \"ORMDL2\",\n          \"class\": \"Gene\",\n          \"start\": 37,\n          \"end\": 43,\n          \"ids\": []\n        },\n        {\n          \"text\": \"GBM\",\n          \"class\": \"Disease\",\n          \"start\": 144,\n          \"end\": 147,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 140, "completion_tokens": 3682, "total_tokens": 3822, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 3520, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41049440", "sentence_id": 7, "text": "Collectively, our findings establish ORMDL2 as a multi-functional macromolecular regulator of immune suppression and therapeutic resistance in GBM, providing new mechanistic insights and potential targets for translational medicines."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683290\", \"sentence_id\": 10, \"text\": \"This study is registered with ClinicalTrials.gov, NCT03395197, and is ongoing.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NdbVdD5nzL7hF6xAfSkYf4vnZq", "object": "chat.completion", "created": 1763443041, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40683290\",\n      \"sentence_id\": 10,\n      \"entities\": []\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 118, "completion_tokens": 813, "total_tokens": 931, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 768, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40683290", "sentence_id": 10, "text": "This study is registered with ClinicalTrials.gov, NCT03395197, and is ongoing."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40848312\", \"sentence_id\": 0, \"text\": \"Prostate cancer (PC) is the second most common cancer and the fifth leading cause of cancer mortality in men, worldwide.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NSnCk4xRtEwR1K7GgR5Vp4TtZN", "object": "chat.completion", "created": 1763443030, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40848312\",\n      \"sentence_id\": 0,\n      \"entities\": [\n        {\n          \"text\": \"Prostate cancer\",\n          \"class\": \"Disease\",\n          \"start\": 0,\n          \"end\": 15,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 124, "completion_tokens": 1686, "total_tokens": 1810, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 1600, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40848312", "sentence_id": 0, "text": "Prostate cancer (PC) is the second most common cancer and the fifth leading cause of cancer mortality in men, worldwide."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40874518\", \"sentence_id\": 9, \"text\": \"The differences in the resistance profiles between olaparib and talazoparib suggest that PARP-trapping potency may play a role in resistance development.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8ND4wOviA2vq5RImLJEBu5okBhP", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40874518\",\n      \"sentence_id\": 9,\n      \"entities\": [\n        {\n          \"text\": \"olaparib\",\n          \"class\": \"Chemical\",\n          \"start\": 51,\n          \"end\": 59,\n          \"ids\": []\n        },\n        {\n          \"text\": \"talazoparib\",\n          \"class\": \"Chemical\",\n          \"start\": 64,\n          \"end\": 75,\n          \"ids\": []\n        },\n        {\n          \"text\": \"PARP\",\n          \"class\": \"Gene\",\n          \"start\": 89,\n          \"end\": 93,\n          \"ids\": []\n        },\n        {\n          \"text\": \"resistance development\",\n          \"class\": \"Phenotype\",\n          \"start\": 130,\n          \"end\": 152,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 130, "completion_tokens": 3854, "total_tokens": 3984, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 3648, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40874518", "sentence_id": 9, "text": "The differences in the resistance profiles between olaparib and talazoparib suggest that PARP-trapping potency may play a role in resistance development."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 10, \"text\": \"and China perspectives, respectively, which were above the willingness-to-pay thresholds ($150,000 in the U.S.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NHIvaevwJiOBaqaN1nrFs6dmmX", "object": "chat.completion", "created": 1763443019, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40873813\",\n      \"sentence_id\": 10,\n      \"entities\": [\n        {\n          \"text\": \"willingness-to-pay thresholds\",\n          \"class\": \"Finding\",\n          \"start\": 59,\n          \"end\": 88,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 122, "completion_tokens": 3548, "total_tokens": 3670, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 3456, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40873813", "sentence_id": 10, "text": "and China perspectives, respectively, which were above the willingness-to-pay thresholds ($150,000 in the U.S."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41216708\", \"sentence_id\": 2, \"text\": \"Biomarker-based patient selection (apart from BRCAness) or combination treatment may increase efficacy.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDKUIR4sf4Sof3XvSL1h3DW2bv", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41216708\",\n      \"sentence_id\": 2,\n      \"entities\": [\n        {\n          \"text\": \"BRCAness\",\n          \"class\": \"Phenotype\",\n          \"start\": 46,\n          \"end\": 53,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 120, "completion_tokens": 3993, "total_tokens": 4113, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 3904, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41216708", "sentence_id": 2, "text": "Biomarker-based patient selection (apart from BRCAness) or combination treatment may increase efficacy."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41216708\", \"sentence_id\": 10, \"text\": \"This new combination treatment allows efficient application of PARPi Talazoparib to all UC patients, independent of Cisplatin pretreatment and genetic BRCAness.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDIan8rIxyeaeM8qZ2OGfeFRRV", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41216708\",\n      \"sentence_id\": 10,\n      \"entities\": [\n        {\"text\": \"PARPi\", \"class\": \"Chemical\", \"start\": 63, \"end\": 68, \"ids\": []},\n        {\"text\": \"Talazoparib\", \"class\": \"Chemical\", \"start\": 69, \"end\": 80, \"ids\": []},\n        {\"text\": \"UC\", \"class\": \"Disease\", \"start\": 88, \"end\": 90, \"ids\": []},\n        {\"text\": \"Cisplatin\", \"class\": \"Chemical\", \"start\": 116, \"end\": 125, \"ids\": []},\n        {\"text\": \"BRCAness\", \"class\": \"Phenotype\", \"start\": 151, \"end\": 160, \"ids\": []}\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 133, "completion_tokens": 4049, "total_tokens": 4182, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 3840, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41216708", "sentence_id": 10, "text": "This new combination treatment allows efficient application of PARPi Talazoparib to all UC patients, independent of Cisplatin pretreatment and genetic BRCAness."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41077155\", \"sentence_id\": 2, \"text\": \"In this study, we conducted a comparative analysis of the four FDA-approved anti-cancer PARPi and their interactions with Pgp to elucidate the mechanisms driving their Pgp-mediated transport.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDElkUZHWoMIUnJZG1MbZNw8PE", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41077155\",\n      \"sentence_id\": 2,\n      \"entities\": [\n        {\n          \"text\": \"PARPi\",\n          \"class\": \"Chemical\",\n          \"start\": 88,\n          \"end\": 93,\n          \"ids\": []\n        },\n        {\n          \"text\": \"Pgp\",\n          \"class\": \"Gene\",\n          \"start\": 122,\n          \"end\": 125,\n          \"ids\": []\n        },\n        {\n          \"text\": \"Pgp\",\n          \"class\": \"Gene\",\n          \"start\": 168,\n          \"end\": 171,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 136, "completion_tokens": 4002, "total_tokens": 4138, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 3840, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41077155", "sentence_id": 2, "text": "In this study, we conducted a comparative analysis of the four FDA-approved anti-cancer PARPi and their interactions with Pgp to elucidate the mechanisms driving their Pgp-mediated transport."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41219112\", \"sentence_id\": 1, \"text\": \"However, metastatic PC is still the third leading cancer-related cause of death among men in Europe, with a 5-yr survival rate of \u223c30% and median overall survival (OS) of <3\u00a0yr for castration-resistant PC (CRPC).\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDm0SWPdSAVLzDnI8BF1qnuOg6", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41219112\",\n      \"sentence_id\": 1,\n      \"entities\": [\n        {\n          \"text\": \"metastatic PC\",\n          \"class\": \"Disease\",\n          \"start\": 9,\n          \"end\": 21,\n          \"ids\": []\n        },\n        {\n          \"text\": \"castration-resistant PC (CRPC)\",\n          \"class\": \"Disease\",\n          \"start\": 179,\n          \"end\": 208,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 153, "completion_tokens": 3267, "total_tokens": 3420, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 3136, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41219112", "sentence_id": 1, "text": "However, metastatic PC is still the third leading cancer-related cause of death among men in Europe, with a 5-yr survival rate of \u223c30% and median overall survival (OS) of <3\u00a0yr for castration-resistant PC (CRPC)."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41049440\", \"sentence_id\": 1, \"text\": \"Emerging evidence suggests that endoplasmic reticulum (ER)-associated macromolecules play critical roles in tumor adaptation.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDUWiBRVn9tnFhiIVSIQAdnRsw", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41049440\",\n      \"sentence_id\": 1,\n      \"entities\": [\n        {\n          \"text\": \"tumor\",\n          \"class\": \"Disease\",\n          \"start\": 108,\n          \"end\": 112,\n          \"ids\": []\n        },\n        {\n          \"text\": \"adaptation\",\n          \"class\": \"Phenotype\",\n          \"start\": 114,\n          \"end\": 123,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 123, "completion_tokens": 4413, "total_tokens": 4536, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 4288, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41049440", "sentence_id": 1, "text": "Emerging evidence suggests that endoplasmic reticulum (ER)-associated macromolecules play critical roles in tumor adaptation."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41216708\", \"sentence_id\": 9, \"text\": \"In conclusion, we suggest Talazoparib treatment of UC to be highly efficacious on all models examined when combined with PLX51107.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDhmnhfsxKP7S62Js6Qpr1jOzG", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41216708\",\n      \"sentence_id\": 9,\n      \"entities\": [\n        {\n          \"text\": \"Talazoparib\",\n          \"class\": \"Chemical\",\n          \"start\": 26,\n          \"end\": 37,\n          \"ids\": []\n        },\n        {\n          \"text\": \"UC\",\n          \"class\": \"Disease\",\n          \"start\": 51,\n          \"end\": 53,\n          \"ids\": []\n        },\n        {\n          \"text\": \"models\",\n          \"class\": \"Model\",\n          \"start\": 86,\n          \"end\": 92,\n          \"ids\": []\n        },\n        {\n          \"text\": \"PLX51107\",\n          \"class\": \"Chemical\",\n          \"start\": 121,\n          \"end\": 129,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 129, "completion_tokens": 3338, "total_tokens": 3467, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 3136, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41216708", "sentence_id": 9, "text": "In conclusion, we suggest Talazoparib treatment of UC to be highly efficacious on all models examined when combined with PLX51107."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683290\", \"sentence_id\": 3, \"text\": \"METHODS: TALAPRO-2 was a randomised, double-blind, placebo-controlled, phase 3 trial.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8Na35hVlYQ8l4Z4CVbiOu7deMg1", "object": "chat.completion", "created": 1763443038, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40683290\",\n      \"sentence_id\": 3,\n      \"entities\": [\n        {\n          \"text\": \"TALAPRO-2\",\n          \"class\": \"Chemical\",\n          \"start\": 9,\n          \"end\": 18,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 124, "completion_tokens": 1561, "total_tokens": 1685, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 1472, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40683290", "sentence_id": 3, "text": "METHODS: TALAPRO-2 was a randomised, double-blind, placebo-controlled, phase 3 trial."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40954422\", \"sentence_id\": 0, \"text\": \"Homologous recombination repair (HRR) is a DNA repair pathway that helps maintain genomic stability.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDOrQ200HPHFhMfio6rs4kPPa4", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40954422\",\n      \"sentence_id\": 0,\n      \"entities\": [\n        {\n          \"text\": \"Homologous recombination repair\",\n          \"class\": \"Pathway\",\n          \"start\": 0,\n          \"end\": 31,\n          \"ids\": []\n        },\n        {\n          \"text\": \"HRR\",\n          \"class\": \"Pathway\",\n          \"start\": 33,\n          \"end\": 36,\n          \"ids\": []\n        },\n        {\n          \"text\": \"genomic stability\",\n          \"class\": \"Phenotype\",\n          \"start\": 82,\n          \"end\": 99,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 120, "completion_tokens": 3561, "total_tokens": 3681, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 3392, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40954422", "sentence_id": 0, "text": "Homologous recombination repair (HRR) is a DNA repair pathway that helps maintain genomic stability."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 15, \"text\": \"CONCLUSION: At current pricing, talazoparib plus enzalutamide as first-line treatment of patients with mCRPC is not cost-effective in either the U.S.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NMI7t0Axzt5CkvnAjDmqtqauxH", "object": "chat.completion", "created": 1763443024, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40873813\",\n      \"sentence_id\": 15,\n      \"entities\": [\n        {\n          \"text\": \"talazoparib\",\n          \"class\": \"Chemical\",\n          \"start\": 32,\n          \"end\": 43,\n          \"ids\": []\n        },\n        {\n          \"text\": \"enzalutamide\",\n          \"class\": \"Chemical\",\n          \"start\": 49,\n          \"end\": 61,\n          \"ids\": []\n        },\n        {\n          \"text\": \"mCRPC\",\n          \"class\": \"Disease\",\n          \"start\": 103,\n          \"end\": 108,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 136, "completion_tokens": 3241, "total_tokens": 3377, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 3072, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40873813", "sentence_id": 15, "text": "CONCLUSION: At current pricing, talazoparib plus enzalutamide as first-line treatment of patients with mCRPC is not cost-effective in either the U.S."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683290\", \"sentence_id\": 17, \"text\": \"FUNDING: Pfizer.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NggNwXixSsV3FkYOhc8jf4pFws", "object": "chat.completion", "created": 1763443044, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40683290\",\n      \"sentence_id\": 17,\n      \"entities\": []\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 105, "completion_tokens": 877, "total_tokens": 982, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 832, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40683290", "sentence_id": 17, "text": "FUNDING: Pfizer."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41219112\", \"sentence_id\": 7, \"text\": \"CONCLUSIONS AND CLINICAL IMPLICATIONS: Promising results have led to the approval of several PARPi agents as monotherapy or in combination with ARPIs in selected or unselected patients when chemotherapy is not clinically indicated.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDduvV8nuiYecGlRvVlkv15f76", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41219112\",\n      \"sentence_id\": 7,\n      \"entities\": [\n        {\n          \"text\": \"PARPi\",\n          \"class\": \"Chemical\",\n          \"start\": 93,\n          \"end\": 98,\n          \"ids\": []\n        },\n        {\n          \"text\": \"ARPIs\",\n          \"class\": \"Chemical\",\n          \"start\": 144,\n          \"end\": 149,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 146, "completion_tokens": 3582, "total_tokens": 3728, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 3456, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41219112", "sentence_id": 7, "text": "CONCLUSIONS AND CLINICAL IMPLICATIONS: Promising results have led to the approval of several PARPi agents as monotherapy or in combination with ARPIs in selected or unselected patients when chemotherapy is not clinically indicated."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41216708\", \"sentence_id\": 5, \"text\": \"By analysis of experimental and public clinical data, we identified new UC-specific PARPi response predictors SLFN5, SLFN11, and OAS1.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDUzlK04v9lL9UsBiJ6jMIhFtl", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41216708\",\n      \"sentence_id\": 5,\n      \"entities\": [\n        {\n          \"text\": \"UC\",\n          \"class\": \"Disease\",\n          \"start\": 72,\n          \"end\": 74,\n          \"ids\": []\n        },\n        {\n          \"text\": \"PARPi\",\n          \"class\": \"Chemical\",\n          \"start\": 84,\n          \"end\": 89,\n          \"ids\": []\n        },\n        {\n          \"text\": \"SLFN5\",\n          \"class\": \"Gene\",\n          \"start\": 110,\n          \"end\": 115,\n          \"ids\": []\n        },\n        {\n          \"text\": \"SLFN11\",\n          \"class\": \"Gene\",\n          \"start\": 117,\n          \"end\": 123,\n          \"ids\": []\n        },\n        {\n          \"text\": \"OAS1\",\n          \"class\": \"Gene\",\n          \"start\": 129,\n          \"end\": 133,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 130, "completion_tokens": 4528, "total_tokens": 4658, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 4288, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41216708", "sentence_id": 5, "text": "By analysis of experimental and public clinical data, we identified new UC-specific PARPi response predictors SLFN5, SLFN11, and OAS1."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 9, \"text\": \"RESULTS: In the base-case analysis, the ICERs for talazoparib plus enzalutamide were $646,743.72/QALY and $57,635.76/QALY from the U.S.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDUM8MBUMGlwFRavkn4tpJd668", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40873813\",\n      \"sentence_id\": 9,\n      \"entities\": [\n        {\n          \"text\": \"talazoparib\",\n          \"class\": \"Chemical\",\n          \"start\": 50,\n          \"end\": 61,\n          \"ids\": []\n        },\n        {\n          \"text\": \"enzalutamide\",\n          \"class\": \"Chemical\",\n          \"start\": 67,\n          \"end\": 79,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 148, "completion_tokens": 4416, "total_tokens": 4564, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 4288, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40873813", "sentence_id": 9, "text": "RESULTS: In the base-case analysis, the ICERs for talazoparib plus enzalutamide were $646,743.72/QALY and $57,635.76/QALY from the U.S."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40954422\", \"sentence_id\": 2, \"text\": \"For adult patients in the USA with mCRPC harboring HRR gene alterations, the combination of talazoparib plus enzalutamide is an approved treatment option.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8ND88bMygM2rfvWRztjMl2NLDdy", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40954422\",\n      \"sentence_id\": 2,\n      \"entities\": [\n        {\n          \"text\": \"mCRPC\",\n          \"class\": \"Disease\",\n          \"start\": 35,\n          \"end\": 39,\n          \"ids\": []\n        },\n        {\n          \"text\": \"HRR\",\n          \"class\": \"Gene\",\n          \"start\": 51,\n          \"end\": 53,\n          \"ids\": []\n        },\n        {\n          \"text\": \"talazoparib\",\n          \"class\": \"Chemical\",\n          \"start\": 92,\n          \"end\": 102,\n          \"ids\": []\n        },\n        {\n          \"text\": \"enzalutamide\",\n          \"class\": \"Chemical\",\n          \"start\": 109,\n          \"end\": 120,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 135, "completion_tokens": 4558, "total_tokens": 4693, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 4352, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40954422", "sentence_id": 2, "text": "For adult patients in the USA with mCRPC harboring HRR gene alterations, the combination of talazoparib plus enzalutamide is an approved treatment option."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41186828\", \"sentence_id\": 6, \"text\": \"Our results showed that the ELI and TAL combination could overcome TAL resistance by downregulating cell cycle checkpoint proteins and ATR-based DDR pathways through synergistic effects (ZIP score\u2009>\u200910).\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDkgPPfy1sW1dxr8s1KbF1iHLC", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41186828\",\n      \"sentence_id\": 6,\n      \"entities\": [\n        {\n          \"text\": \"ATR\",\n          \"class\": \"Gene\",\n          \"start\": 135,\n          \"end\": 138,\n          \"ids\": []\n        },\n        {\n          \"text\": \"DDR\",\n          \"class\": \"Pathway\",\n          \"start\": 145,\n          \"end\": 148,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 139, "completion_tokens": 3967, "total_tokens": 4106, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 3840, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41186828", "sentence_id": 6, "text": "Our results showed that the ELI and TAL combination could overcome TAL resistance by downregulating cell cycle checkpoint proteins and ATR-based DDR pathways through synergistic effects (ZIP score\u2009>\u200910)."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41219112\", \"sentence_id\": 2, \"text\": \"Current strategies are moving towards personalised treatment, with the emergence of PARP inhibitors (PARPi) that exploit a vulnerability in the DNA repair system in patients with alterations in genes involved in homologous recombination.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDHSfkjLgjoY4gUcXovqVtNwbe", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41219112\",\n      \"sentence_id\": 2,\n      \"entities\": [\n        {\n          \"text\": \"PARP inhibitors\",\n          \"class\": \"Chemical\",\n          \"start\": 84,\n          \"end\": 99,\n          \"ids\": []\n        },\n        {\n          \"text\": \"DNA repair\",\n          \"class\": \"Pathway\",\n          \"start\": 143,\n          \"end\": 153,\n          \"ids\": []\n        },\n        {\n          \"text\": \"homologous recombination\",\n          \"class\": \"Pathway\",\n          \"start\": 211,\n          \"end\": 233,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 140, "completion_tokens": 4713, "total_tokens": 4853, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 4544, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41219112", "sentence_id": 2, "text": "Current strategies are moving towards personalised treatment, with the emergence of PARP inhibitors (PARPi) that exploit a vulnerability in the DNA repair system in patients with alterations in genes involved in homologous recombination."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41186828\", \"sentence_id\": 0, \"text\": \"Poly(ADP-ribose) polymerase (PARP) inhibitors (PARPi) have attracted significant attention in triple negative breast cancer (TNBC) treatment.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDpZZ5kHMQiS4xVJGhTtT56lLT", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41186828\",\n      \"sentence_id\": 0,\n      \"entities\": [\n        {\n          \"text\": \"Poly(ADP-ribose) polymerase\",\n          \"class\": \"Gene\",\n          \"start\": 0,\n          \"end\": 26,\n          \"ids\": []\n        },\n        {\n          \"text\": \"triple negative breast cancer\",\n          \"class\": \"Disease\",\n          \"start\": 94,\n          \"end\": 123,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 133, "completion_tokens": 4808, "total_tokens": 4941, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 4672, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41186828", "sentence_id": 0, "text": "Poly(ADP-ribose) polymerase (PARP) inhibitors (PARPi) have attracted significant attention in triple negative breast cancer (TNBC) treatment."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40874518\", \"sentence_id\": 6, \"text\": \"Talazoparib-resistant cells exhibited a similar resistance profile to cisplatin-resistant cells, including decreased PARP1 expression and altered metabolomic profiles.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDZbagktEzFCpeDKTOlJZTUKZ0", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40874518\",\n      \"sentence_id\": 6,\n      \"entities\": [\n        {\n          \"text\": \"Talazoparib\",\n          \"class\": \"Chemical\",\n          \"start\": 0,\n          \"end\": 11,\n          \"ids\": []\n        },\n        {\n          \"text\": \"cisplatin\",\n          \"class\": \"Chemical\",\n          \"start\": 70,\n          \"end\": 79,\n          \"ids\": []\n        },\n        {\n          \"text\": \"PARP1\",\n          \"class\": \"Gene\",\n          \"start\": 117,\n          \"end\": 122,\n          \"ids\": []\n        },\n        {\n          \"text\": \"metabolomic profiles\",\n          \"class\": \"Phenotype\",\n          \"start\": 146,\n          \"end\": 166,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 130, "completion_tokens": 3983, "total_tokens": 4113, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 3776, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40874518", "sentence_id": 6, "text": "Talazoparib-resistant cells exhibited a similar resistance profile to cisplatin-resistant cells, including decreased PARP1 expression and altered metabolomic profiles."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41173779\", \"sentence_id\": 2, \"text\": \"METHODS: TALAPRO-1 evaluated talazoparib monotherapy in heavily pretreated patients with mCRPC and DDR-HRR alterations.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDitmAL2kHvZZgCEDcpsEJnAmT", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41173779\",\n      \"sentence_id\": 2,\n      \"entities\": [\n        {\n          \"text\": \"TALAPRO-1\",\n          \"class\": \"Model\",\n          \"start\": 9,\n          \"end\": 18,\n          \"ids\": []\n        },\n        {\n          \"text\": \"talazoparib\",\n          \"class\": \"Chemical\",\n          \"start\": 29,\n          \"end\": 40,\n          \"ids\": []\n        },\n        {\n          \"text\": \"mCRPC\",\n          \"class\": \"Disease\",\n          \"start\": 89,\n          \"end\": 94,\n          \"ids\": []\n        },\n        {\n          \"text\": \"DDR-HRR alterations\",\n          \"class\": \"Mutation\",\n          \"start\": 99,\n          \"end\": 118,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 130, "completion_tokens": 4049, "total_tokens": 4179, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 3840, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41173779", "sentence_id": 2, "text": "METHODS: TALAPRO-1 evaluated talazoparib monotherapy in heavily pretreated patients with mCRPC and DDR-HRR alterations."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40874518\", \"sentence_id\": 1, \"text\": \"PARP inhibitors (PARPi) have shown promise in treating PDAC with homologous recombination deficiency (HRD), but rapid acquisition of resistance limits their efficacy.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8ND2wKPm83tQxtRLoD6XCfe5d0j", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40874518\",\n      \"sentence_id\": 1,\n      \"entities\": [\n        {\n          \"text\": \"PARP inhibitors\",\n          \"class\": \"Chemical\",\n          \"start\": 0,\n          \"end\": 15,\n          \"ids\": []\n        },\n        {\n          \"text\": \"PARPi\",\n          \"class\": \"Chemical\",\n          \"start\": 17,\n          \"end\": 22,\n          \"ids\": []\n        },\n        {\n          \"text\": \"PDAC\",\n          \"class\": \"Disease\",\n          \"start\": 55,\n          \"end\": 59,\n          \"ids\": []\n        },\n        {\n          \"text\": \"homologous recombination deficiency\",\n          \"class\": \"Phenotype\",\n          \"start\": 64,\n          \"end\": 100,\n          \"ids\": []\n        },\n        {\n          \"text\": \"HRD\",\n          \"class\": \"Phenotype\",\n          \"start\": 102,\n          \"end\": 105,\n          \"ids\": []\n        },\n        {\n          \"text\": \"resistance\",\n          \"class\": \"Phenotype\",\n          \"start\": 133,\n          \"end\": 143,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 132, "completion_tokens": 4956, "total_tokens": 5088, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 4672, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40874518", "sentence_id": 1, "text": "PARP inhibitors (PARPi) have shown promise in treating PDAC with homologous recombination deficiency (HRD), but rapid acquisition of resistance limits their efficacy."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40874518\", \"sentence_id\": 4, \"text\": \"We also developed a cisplatin-resistant Capan-1 cell line to compare resistance mechanisms between PARPi and platinum agents.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDFAemcCrdkeUgYBklmAFyX9VX", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40874518\",\n      \"sentence_id\": 4,\n      \"entities\": [\n        {\"text\": \"cisplatin\", \"class\": \"Chemical\", \"start\": 20, \"end\": 29, \"ids\": []},\n        {\"text\": \"Capan-1\", \"class\": \"Model\", \"start\": 40, \"end\": 47, \"ids\": []},\n        {\"text\": \"resistance\", \"class\": \"Phenotype\", \"start\": 70, \"end\": 80, \"ids\": []},\n        {\"text\": \"PARPi\", \"class\": \"Chemical\", \"start\": 99, \"end\": 104, \"ids\": []},\n        {\"text\": \"platinum\", \"class\": \"Chemical\", \"start\": 109, \"end\": 117, \"ids\": []}\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 124, "completion_tokens": 4879, "total_tokens": 5003, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 4672, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40874518", "sentence_id": 4, "text": "We also developed a cisplatin-resistant Capan-1 cell line to compare resistance mechanisms between PARPi and platinum agents."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41049440\", \"sentence_id\": 2, \"text\": \"In this study, we performed a multi-omics investigation of orosomucoid-like protein 2 (ORMDL2), a conserved ER membrane protein involved in sphingolipid biosynthesis and ER stress regulation, and uncovered its regulatory functions in GBM progression.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDVQdbrKBC0BfMfHWJuQtA17yw", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41049440\",\n      \"sentence_id\": 2,\n      \"entities\": [\n        {\n          \"text\": \"orosomucoid-like protein 2 (ORMDL2)\",\n          \"class\": \"Gene\",\n          \"start\": 59,\n          \"end\": 94,\n          \"ids\": []\n        },\n        {\n          \"text\": \"sphingolipid biosynthesis\",\n          \"class\": \"Pathway\",\n          \"start\": 138,\n          \"end\": 164,\n          \"ids\": []\n        },\n        {\n          \"text\": \"GBM\",\n          \"class\": \"Disease\",\n          \"start\": 233,\n          \"end\": 236,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 153, "completion_tokens": 5813, "total_tokens": 5966, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 5632, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41049440", "sentence_id": 2, "text": "In this study, we performed a multi-omics investigation of orosomucoid-like protein 2 (ORMDL2), a conserved ER membrane protein involved in sphingolipid biosynthesis and ER stress regulation, and uncovered its regulatory functions in GBM progression."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683290\", \"sentence_id\": 8, \"text\": \"Follow-up for overall survival was intended to continue until the planned final analysis.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NcmThqcu8w4zIRZBgaQ3U7uka7", "object": "chat.completion", "created": 1763443040, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40683290\",\n      \"sentence_id\": 8,\n      \"entities\": [\n        {\n          \"text\": \"overall survival\",\n          \"class\": \"Phenotype\",\n          \"start\": 14,\n          \"end\": 30,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 114, "completion_tokens": 1815, "total_tokens": 1929, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 1728, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40683290", "sentence_id": 8, "text": "Follow-up for overall survival was intended to continue until the planned final analysis."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41186828\", \"sentence_id\": 3, \"text\": \"We aimed to assess the efficacy of ATR and PARP inhibitors combination in TNBC cells and the reversal of PARPi resistance in resistant cells.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDgF1duK1AWWIHsvD34izPpi2e", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41186828\",\n      \"sentence_id\": 3,\n      \"entities\": [\n        {\n          \"text\": \"ATR\",\n          \"class\": \"Gene\",\n          \"start\": 35,\n          \"end\": 38,\n          \"ids\": []\n        },\n        {\n          \"text\": \"PARP inhibitors\",\n          \"class\": \"Chemical\",\n          \"start\": 43,\n          \"end\": 58,\n          \"ids\": []\n        },\n        {\n          \"text\": \"TNBC\",\n          \"class\": \"Disease\",\n          \"start\": 74,\n          \"end\": 78,\n          \"ids\": []\n        },\n        {\n          \"text\": \"PARPi\",\n          \"class\": \"Chemical\",\n          \"start\": 105,\n          \"end\": 110,\n          \"ids\": []\n        },\n        {\n          \"text\": \"resistance\",\n          \"class\": \"Phenotype\",\n          \"start\": 111,\n          \"end\": 121,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 127, "completion_tokens": 4847, "total_tokens": 4974, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 4608, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41186828", "sentence_id": 3, "text": "We aimed to assess the efficacy of ATR and PARP inhibitors combination in TNBC cells and the reversal of PARPi resistance in resistant cells."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40661990\", \"sentence_id\": 2, \"text\": \"payer perspective.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NqUob1fjwkZuv7OdJMFmaIVZSs", "object": "chat.completion", "created": 1763443054, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40661990\",\n      \"sentence_id\": 2,\n      \"entities\": []\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 102, "completion_tokens": 301, "total_tokens": 403, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 256, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40661990", "sentence_id": 2, "text": "payer perspective."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683290\", \"sentence_id\": 1, \"text\": \"Overall survival data were immature at that time.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NZpSbWx0OI0UCpy7w5PT8i3Dwo", "object": "chat.completion", "created": 1763443037, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40683290\",\n      \"sentence_id\": 1,\n      \"entities\": [\n        {\n          \"text\": \"Overall survival\",\n          \"class\": \"Finding\",\n          \"start\": 0,\n          \"end\": 15,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 108, "completion_tokens": 2198, "total_tokens": 2306, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 2112, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40683290", "sentence_id": 1, "text": "Overall survival data were immature at that time."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40954422\", \"sentence_id\": 1, \"text\": \"About one quarter of patients with metastatic castration-resistant prostate cancer (mCRPC) have alterations in HRR genes.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8ND45DL7ocs59FJ37H3Inlk86RO", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40954422\",\n      \"sentence_id\": 1,\n      \"entities\": [\n        {\n          \"text\": \"metastatic castration-resistant prostate cancer\",\n          \"class\": \"Disease\",\n          \"start\": 35,\n          \"end\": 82,\n          \"ids\": []\n        },\n        {\n          \"text\": \"HRR genes\",\n          \"class\": \"Gene\",\n          \"start\": 83,\n          \"end\": 92,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 123, "completion_tokens": 4418, "total_tokens": 4541, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 4288, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40954422", "sentence_id": 1, "text": "About one quarter of patients with metastatic castration-resistant prostate cancer (mCRPC) have alterations in HRR genes."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41077155\", \"sentence_id\": 4, \"text\": \"Rucaparib and niraparib slightly increased Pgp activity at lower concentrations but displayed biphasic kinetic trends and predominantly reduced Pgp ATPase activity below basal levels.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDkvRXNE5exzqvVMGN6BAD3Rg4", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41077155\",\n      \"sentence_id\": 4,\n      \"entities\": [\n        {\n          \"text\": \"Rucaparib\",\n          \"class\": \"Chemical\",\n          \"start\": 0,\n          \"end\": 9,\n          \"ids\": []\n        },\n        {\n          \"text\": \"niraparib\",\n          \"class\": \"Chemical\",\n          \"start\": 14,\n          \"end\": 23,\n          \"ids\": []\n        },\n        {\n          \"text\": \"Pgp activity\",\n          \"class\": \"Phenotype\",\n          \"start\": 43,\n          \"end\": 55,\n          \"ids\": []\n        },\n        {\n          \"text\": \"Pgp ATPase activity\",\n          \"class\": \"Phenotype\",\n          \"start\": 144,\n          \"end\": 162,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 134, "completion_tokens": 4114, "total_tokens": 4248, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 3904, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41077155", "sentence_id": 4, "text": "Rucaparib and niraparib slightly increased Pgp activity at lower concentrations but displayed biphasic kinetic trends and predominantly reduced Pgp ATPase activity below basal levels."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41216708\", \"sentence_id\": 4, \"text\": \"RNA sequencing of PARPi-treated UC lines revealed few common targets and a different impact on immune response.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8ND0nOFkvRLBr7pXb15PonFTNq4", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41216708\",\n      \"sentence_id\": 4,\n      \"entities\": [\n        {\"text\": \"RNA sequencing\", \"class\": \"Finding\", \"start\": 0, \"end\": 13, \"ids\": []},\n        {\"text\": \"PARPi\", \"class\": \"Chemical\", \"start\": 18, \"end\": 22, \"ids\": []},\n        {\"text\": \"UC lines\", \"class\": \"Model\", \"start\": 32, \"end\": 39, \"ids\": []},\n        {\"text\": \"immune response\", \"class\": \"Phenotype\", \"start\": 95, \"end\": 109, \"ids\": []}\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 119, "completion_tokens": 5357, "total_tokens": 5476, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 5184, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41216708", "sentence_id": 4, "text": "RNA sequencing of PARPi-treated UC lines revealed few common targets and a different impact on immune response."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683287\", \"sentence_id\": 10, \"text\": \"For statistical significance at the final overall survival analysis, the two-sided p value from the stratified log-rank test needed to be 0\u00b7024 or less based on a group sequential design with O'Brien-Fleming spending function.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NlmbE36aSUlWh8pRxIFV2aPSAn", "object": "chat.completion", "created": 1763443049, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40683287\",\n      \"sentence_id\": 10,\n      \"entities\": []\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 146, "completion_tokens": 1005, "total_tokens": 1151, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 960, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40683287", "sentence_id": 10, "text": "For statistical significance at the final overall survival analysis, the two-sided p value from the stratified log-rank test needed to be 0\u00b7024 or less based on a group sequential design with O'Brien-Fleming spending function."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683287\", \"sentence_id\": 12, \"text\": \"The trial is registered with ClinicalTrials.gov, NCT03395197.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NlkOOI6vH7f3sxmkLNtt6XuTVt", "object": "chat.completion", "created": 1763443049, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40683287\",\n      \"sentence_id\": 12,\n      \"entities\": []\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 114, "completion_tokens": 1069, "total_tokens": 1183, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 1024, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40683287", "sentence_id": 12, "text": "The trial is registered with ClinicalTrials.gov, NCT03395197."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40848312\", \"sentence_id\": 4, \"text\": \"This non-systematic narrative review aims to summarize current evidence on PARPi in PC, outlining approved indications, ongoing clinical trials, and emerging therapeutic strategies across different disease settings.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NYMZW3jY7juL4r6ETCajc569Ea", "object": "chat.completion", "created": 1763443036, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40848312\",\n      \"sentence_id\": 4,\n      \"entities\": [\n        {\n          \"text\": \"PARPi\",\n          \"class\": \"Chemical\",\n          \"start\": 75,\n          \"end\": 79,\n          \"ids\": []\n        },\n        {\n          \"text\": \"PC\",\n          \"class\": \"Disease\",\n          \"start\": 84,\n          \"end\": 85,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 133, "completion_tokens": 2811, "total_tokens": 2944, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 2688, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40848312", "sentence_id": 4, "text": "This non-systematic narrative review aims to summarize current evidence on PARPi in PC, outlining approved indications, ongoing clinical trials, and emerging therapeutic strategies across different disease settings."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41077155\", \"sentence_id\": 5, \"text\": \"Quenching of Pgp's intrinsic tryptophan residues revealed high binding affinities for the PARPi-Pgp complexes, apart from talazoparib, which displayed relatively lower affinity.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8ND0gYyl4IHiTRKO3xMzA3vD4KE", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41077155\",\n      \"sentence_id\": 5,\n      \"entities\": [\n        {\"text\": \"Pgp\", \"class\": \"Gene\", \"start\": 13, \"end\": 16, \"ids\": []},\n        {\"text\": \"tryptophan\", \"class\": \"Chemical\", \"start\": 29, \"end\": 39, \"ids\": []},\n        {\"text\": \"PARPi\", \"class\": \"Chemical\", \"start\": 90, \"end\": 95, \"ids\": []},\n        {\"text\": \"Pgp\", \"class\": \"Gene\", \"start\": 96, \"end\": 99, \"ids\": []},\n        {\"text\": \"talazoparib\", \"class\": \"Chemical\", \"start\": 122, \"end\": 133, \"ids\": []},\n        {\"text\": \"affinity\", \"class\": \"Finding\", \"start\": 168, \"end\": 176, \"ids\": []}\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 138, "completion_tokens": 5550, "total_tokens": 5688, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 5312, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41077155", "sentence_id": 5, "text": "Quenching of Pgp's intrinsic tryptophan residues revealed high binding affinities for the PARPi-Pgp complexes, apart from talazoparib, which displayed relatively lower affinity."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 1, \"text\": \"Given the substantial cost implications of novel targeted therapies, economic evaluation is essential to determine whether the clinical benefits of this regimen justify its expense in the first-line mCRPC setting.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8ND59Ha4LfyjpXa44bP1h0CynpX", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40873813\",\n      \"sentence_id\": 1,\n      \"entities\": [\n        {\n          \"text\": \"targeted therapies\",\n          \"class\": \"Chemical\",\n          \"start\": 49,\n          \"end\": 67,\n          \"ids\": []\n        },\n        {\n          \"text\": \"mCRPC\",\n          \"class\": \"Disease\",\n          \"start\": 200,\n          \"end\": 204,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 134, "completion_tokens": 4670, "total_tokens": 4804, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 4544, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40873813", "sentence_id": 1, "text": "Given the substantial cost implications of novel targeted therapies, economic evaluation is essential to determine whether the clinical benefits of this regimen justify its expense in the first-line mCRPC setting."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41077155\", \"sentence_id\": 8, \"text\": \"Bi-directional transport assays suggested the rate of Pgp-mediated efflux to be olaparib\u00a0>\u00a0talazoparib\u00a0>\u00a0rucaparib\u00a0>\u00a0niraparib.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8ND4wFl8R35ruphYk54V9mbC4qQ", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41077155\",\n      \"sentence_id\": 8,\n      \"entities\": [\n        {\n          \"text\": \"Pgp\",\n          \"class\": \"Gene\",\n          \"start\": 54,\n          \"end\": 56,\n          \"ids\": []\n        },\n        {\n          \"text\": \"olaparib\",\n          \"class\": \"Chemical\",\n          \"start\": 80,\n          \"end\": 87,\n          \"ids\": []\n        },\n        {\n          \"text\": \"talazoparib\",\n          \"class\": \"Chemical\",\n          \"start\": 91,\n          \"end\": 101,\n          \"ids\": []\n        },\n        {\n          \"text\": \"rucaparib\",\n          \"class\": \"Chemical\",\n          \"start\": 105,\n          \"end\": 113,\n          \"ids\": []\n        },\n        {\n          \"text\": \"niraparib\",\n          \"class\": \"Chemical\",\n          \"start\": 117,\n          \"end\": 125,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 140, "completion_tokens": 5301, "total_tokens": 5441, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 5056, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41077155", "sentence_id": 8, "text": "Bi-directional transport assays suggested the rate of Pgp-mediated efflux to be olaparib\u00a0>\u00a0talazoparib\u00a0>\u00a0rucaparib\u00a0>\u00a0niraparib."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683287\", \"sentence_id\": 20, \"text\": \"FUNDING: Pfizer.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8Np89Ao9pQZP1jisndCsTaI3tCD", "object": "chat.completion", "created": 1763443053, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40683287\",\n      \"sentence_id\": 20,\n      \"entities\": []\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 105, "completion_tokens": 878, "total_tokens": 983, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 832, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40683287", "sentence_id": 20, "text": "FUNDING: Pfizer."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41173779\", \"sentence_id\": 10, \"text\": \"The median OS for gLOH-high patients was 23.7\u00a0mo versus 18.7\u00a0mo for gLOH-low patients (hazard ratio 0.92, 95% confidence interval 0.52-1.64).\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDYTVRO9IkqaTRKxy2MgAgjZMg", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41173779\",\n      \"sentence_id\": 10,\n      \"entities\": [\n        {\n          \"text\": \"gLOH-high\",\n          \"class\": \"Phenotype\",\n          \"start\": 18,\n          \"end\": 27,\n          \"ids\": []\n        },\n        {\n          \"text\": \"23.7 mo\",\n          \"class\": \"Finding\",\n          \"start\": 41,\n          \"end\": 47,\n          \"ids\": []\n        },\n        {\n          \"text\": \"18.7 mo\",\n          \"class\": \"Finding\",\n          \"start\": 53,\n          \"end\": 58,\n          \"ids\": []\n        },\n        {\n          \"text\": \"gLOH-low\",\n          \"class\": \"Phenotype\",\n          \"start\": 65,\n          \"end\": 73,\n          \"ids\": []\n        },\n        {\n          \"text\": \"hazard ratio 0.92, 95% confidence interval 0.52-1.64\",\n          \"class\": \"Finding\",\n          \"start\": 84,\n          \"end\": 136,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 152, "completion_tokens": 4618, "total_tokens": 4770, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 4352, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41173779", "sentence_id": 10, "text": "The median OS for gLOH-high patients was 23.7\u00a0mo versus 18.7\u00a0mo for gLOH-low patients (hazard ratio 0.92, 95% confidence interval 0.52-1.64)."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40661990\", \"sentence_id\": 12, \"text\": \"payer perspective.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8Nt7Oa1JkoWuKaJAzOTGoUbzGWM", "object": "chat.completion", "created": 1763443057, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40661990\",\n      \"sentence_id\": 12,\n      \"entities\": []\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 102, "completion_tokens": 493, "total_tokens": 595, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 448, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40661990", "sentence_id": 12, "text": "payer perspective."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683287\", \"sentence_id\": 4, \"text\": \"METHODS: TALAPRO-2 is an ongoing international, randomised, double-blind, placebo-controlled phase 3 trial.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NifNjjAiCHkrDDpBPyXhzfvEwM", "object": "chat.completion", "created": 1763443046, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40683287\",\n      \"sentence_id\": 4,\n      \"entities\": [\n        {\n          \"text\": \"TALAPRO-2\",\n          \"class\": \"Chemical\",\n          \"start\": 9,\n          \"end\": 18,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 126, "completion_tokens": 1753, "total_tokens": 1879, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 1664, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40683287", "sentence_id": 4, "text": "METHODS: TALAPRO-2 is an ongoing international, randomised, double-blind, placebo-controlled phase 3 trial."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40954422\", \"sentence_id\": 3, \"text\": \"The objective of this podcast, featuring two nurse practitioners, is to provide information for oncology nurses and advanced practice providers (APPs) on the use of talazoparib plus enzalutamide and its practical implementation aspects in the clinic.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8ND3Ee95vAmiLqKXV9NFVzzRByl", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40954422\",\n      \"sentence_id\": 3,\n      \"entities\": [\n        {\n          \"text\": \"talazoparib\",\n          \"class\": \"Chemical\",\n          \"start\": 165,\n          \"end\": 175,\n          \"ids\": []\n        },\n        {\n          \"text\": \"enzalutamide\",\n          \"class\": \"Chemical\",\n          \"start\": 182,\n          \"end\": 193,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 148, "completion_tokens": 4801, "total_tokens": 4949, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 4672, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40954422", "sentence_id": 3, "text": "The objective of this podcast, featuring two nurse practitioners, is to provide information for oncology nurses and advanced practice providers (APPs) on the use of talazoparib plus enzalutamide and its practical implementation aspects in the clinic."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41173779\", \"sentence_id\": 0, \"text\": \"BACKGROUND AND OBJECTIVE: The impact of alterations beyond DNA damage response-homologous recombination repair (DDR-HRR) genes on outcomes with poly(ADP-ribose) polymerase inhibitor monotherapy remains unknown.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NFlU3HOog64oCHzTNdeAIO5IZL", "object": "chat.completion", "created": 1763443017, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41173779\",\n      \"sentence_id\": 0,\n      \"entities\": [\n        {\n          \"text\": \"DNA damage response-homologous recombination repair\",\n          \"class\": \"Pathway\",\n          \"start\": null,\n          \"end\": null,\n          \"ids\": []\n        },\n        {\n          \"text\": \"DDR-HRR\",\n          \"class\": \"Pathway\",\n          \"start\": null,\n          \"end\": null,\n          \"ids\": []\n        },\n        {\n          \"text\": \"poly(ADP-ribose) polymerase inhibitor\",\n          \"class\": \"Chemical\",\n          \"start\": null,\n          \"end\": null,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 144, "completion_tokens": 4657, "total_tokens": 4801, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 4480, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41173779", "sentence_id": 0, "text": "BACKGROUND AND OBJECTIVE: The impact of alterations beyond DNA damage response-homologous recombination repair (DDR-HRR) genes on outcomes with poly(ADP-ribose) polymerase inhibitor monotherapy remains unknown."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41173779\", \"sentence_id\": 1, \"text\": \"This study aims to explore the impact of genomic features and co-occurring alterations on treatment outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) and DDR-HRR alterations in TALAPRO-1.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDAx5I1m9l5JSEZjMQrVK0QSft", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41173779\",\n      \"sentence_id\": 1,\n      \"entities\": [\n        {\n          \"text\": \"metastatic castration-resistant prostate cancer\",\n          \"class\": \"Disease\",\n          \"start\": 126,\n          \"end\": 173,\n          \"ids\": []\n        },\n        {\n          \"text\": \"DDR-HRR\",\n          \"class\": \"Pathway\",\n          \"start\": 186,\n          \"end\": 193,\n          \"ids\": []\n        },\n        {\n          \"text\": \"TALAPRO-1\",\n          \"class\": \"Paper\",\n          \"start\": 209,\n          \"end\": 218,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 143, "completion_tokens": 4910, "total_tokens": 5053, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 4736, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41173779", "sentence_id": 1, "text": "This study aims to explore the impact of genomic features and co-occurring alterations on treatment outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) and DDR-HRR alterations in TALAPRO-1."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40874518\", \"sentence_id\": 5, \"text\": \"Both olaparib- and talazoparib-resistant cells showed cross-resistance to other PARPi and oxaliplatin, but not to gemcitabine or 5-FU.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NEf1erNkx9P0xDqojQurZZeKWr", "object": "chat.completion", "created": 1763443016, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40874518\",\n      \"sentence_id\": 5,\n      \"entities\": [\n        {\"text\": \"olaparib\", \"class\": \"Chemical\", \"start\": 5, \"end\": 12, \"ids\": []},\n        {\"text\": \"talazoparib\", \"class\": \"Chemical\", \"start\": 19, \"end\": 29, \"ids\": []},\n        {\"text\": \"cross-resistance\", \"class\": \"Phenotype\", \"start\": 54, \"end\": 69, \"ids\": []},\n        {\"text\": \"PARPi\", \"class\": \"Chemical\", \"start\": 80, \"end\": 84, \"ids\": []},\n        {\"text\": \"oxaliplatin\", \"class\": \"Chemical\", \"start\": 90, \"end\": 100, \"ids\": []},\n        {\"text\": \"gemcitabine\", \"class\": \"Chemical\", \"start\": 114, \"end\": 124, \"ids\": []},\n        {\"text\": \"5-FU\", \"class\": \"Chemical\", \"start\": 129, \"end\": 132, \"ids\": []}\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 139, "completion_tokens": 5523, "total_tokens": 5662, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 5248, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40874518", "sentence_id": 5, "text": "Both olaparib- and talazoparib-resistant cells showed cross-resistance to other PARPi and oxaliplatin, but not to gemcitabine or 5-FU."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683287\", \"sentence_id\": 2, \"text\": \"At primary analysis, overall survival was immature.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NhobTX8JAxeESOD0AfXDxAah2n", "object": "chat.completion", "created": 1763443045, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40683287\",\n      \"sentence_id\": 2,\n      \"entities\": [\n        {\n          \"text\": \"overall survival\",\n          \"class\": \"Finding\",\n          \"start\": 21,\n          \"end\": 37,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 108, "completion_tokens": 3029, "total_tokens": 3137, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 2944, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40683287", "sentence_id": 2, "text": "At primary analysis, overall survival was immature."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41186828\", \"sentence_id\": 5, \"text\": \"Then, the cytotoxic, apoptotic and ATR based DNA damage response (DDR) were evaluated by WST-1, Annexin V, AO/PI, cell cycle and western blot analysis.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDQLZq5VgIJzXkNvrsRhw8loMj", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41186828\",\n      \"sentence_id\": 5,\n      \"entities\": [\n        {\n          \"text\": \"apoptotic\",\n          \"class\": \"Phenotype\",\n          \"start\": 19,\n          \"end\": 28,\n          \"ids\": []\n        },\n        {\n          \"text\": \"ATR\",\n          \"class\": \"Gene\",\n          \"start\": 33,\n          \"end\": 36,\n          \"ids\": []\n        },\n        {\n          \"text\": \"DNA damage response\",\n          \"class\": \"Pathway\",\n          \"start\": 43,\n          \"end\": 62,\n          \"ids\": []\n        },\n        {\n          \"text\": \"DDR\",\n          \"class\": \"Pathway\",\n          \"start\": 64,\n          \"end\": 67,\n          \"ids\": []\n        },\n        {\n          \"text\": \"WST-1\",\n          \"class\": \"Chemical\",\n          \"start\": 87,\n          \"end\": 92,\n          \"ids\": []\n        },\n        {\n          \"text\": \"Annexin V\",\n          \"class\": \"Chemical\",\n          \"start\": 94,\n          \"end\": 103,\n          \"ids\": []\n        },\n        {\n          \"text\": \"AO/PI\",\n          \"class\": \"Chemical\",\n          \"start\": 105,\n          \"end\": 110,\n          \"ids\": []\n        },\n        {\n          \"text\": \"cell cycle\",\n          \"class\": \"Pathway\",\n          \"start\": 112,\n          \"end\": 123,\n          \"ids\": []\n        },\n        {\n          \"text\": \"western blot\",\n          \"class\": \"Finding\",\n          \"start\": 127,\n          \"end\": 139,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 139, "completion_tokens": 5649, "total_tokens": 5788, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 5248, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41186828", "sentence_id": 5, "text": "Then, the cytotoxic, apoptotic and ATR based DNA damage response (DDR) were evaluated by WST-1, Annexin V, AO/PI, cell cycle and western blot analysis."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 2, \"text\": \"OBJECTIVES: To evaluate the cost-effectiveness of talazoparib plus enzalutamide versus enzalutamide monotherapy as first-line treatment for mCRPC, informing clinical decision-making and healthcare resource allocation.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDcRRuulp54v1mfLNwKf4Lbuyv", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40873813\",\n      \"sentence_id\": 2,\n      \"entities\": [\n        {\n          \"text\": \"talazoparib\",\n          \"class\": \"Chemical\",\n          \"start\": 50,\n          \"end\": 61,\n          \"ids\": []\n        },\n        {\n          \"text\": \"enzalutamide\",\n          \"class\": \"Chemical\",\n          \"start\": 67,\n          \"end\": 79,\n          \"ids\": []\n        },\n        {\n          \"text\": \"enzalutamide\",\n          \"class\": \"Chemical\",\n          \"start\": 87,\n          \"end\": 99,\n          \"ids\": []\n        },\n        {\n          \"text\": \"mCRPC\",\n          \"class\": \"Disease\",\n          \"start\": 140,\n          \"end\": 145,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 144, "completion_tokens": 5647, "total_tokens": 5791, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 5440, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40873813", "sentence_id": 2, "text": "OBJECTIVES: To evaluate the cost-effectiveness of talazoparib plus enzalutamide versus enzalutamide monotherapy as first-line treatment for mCRPC, informing clinical decision-making and healthcare resource allocation."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41173779\", \"sentence_id\": 9, \"text\": \"ORR was significantly higher for gLOH-high than for gLOH-low patients (53.3% vs 12.0%; p\u00a0=\u00a00.0017).\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDmxNYfhlIa7wJJQokLalyLcYf", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41173779\",\n      \"sentence_id\": 9,\n      \"entities\": [\n        {\n          \"text\": \"ORR\",\n          \"class\": \"Finding\",\n          \"start\": 0,\n          \"end\": 3,\n          \"ids\": []\n        },\n        {\n          \"text\": \"gLOH-high\",\n          \"class\": \"Phenotype\",\n          \"start\": 33,\n          \"end\": 42,\n          \"ids\": []\n        },\n        {\n          \"text\": \"gLOH-low\",\n          \"class\": \"Phenotype\",\n          \"start\": 52,\n          \"end\": 60,\n          \"ids\": []\n        },\n        {\n          \"text\": \"53.3%\",\n          \"class\": \"Finding\",\n          \"start\": 71,\n          \"end\": 76,\n          \"ids\": []\n        },\n        {\n          \"text\": \"12.0%\",\n          \"class\": \"Finding\",\n          \"start\": 80,\n          \"end\": 85,\n          \"ids\": []\n        },\n        {\n          \"text\": \"p = 0.0017\",\n          \"class\": \"Finding\",\n          \"start\": 87,\n          \"end\": 97,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 137, "completion_tokens": 4831, "total_tokens": 4968, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 4544, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41173779", "sentence_id": 9, "text": "ORR was significantly higher for gLOH-high than for gLOH-low patients (53.3% vs 12.0%; p\u00a0=\u00a00.0017)."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40874518\", \"sentence_id\": 2, \"text\": \"Our objective is to investigate mechanisms of resistance to PARPi in BRCA2-mutant PDAC cells and identify potential therapeutic targets to modulate this resistance.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDsjJQC0zArto7nfGGbRXTEsZs", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40874518\",\n      \"sentence_id\": 2,\n      \"entities\": [\n        {\"text\": \"resistance\", \"class\": \"Phenotype\", \"start\": 46, \"end\": 56, \"ids\": []},\n        {\"text\": \"PARPi\", \"class\": \"Chemical\", \"start\": 60, \"end\": 65, \"ids\": []},\n        {\"text\": \"BRCA2\", \"class\": \"Gene\", \"start\": 69, \"end\": 74, \"ids\": []},\n        {\"text\": \"BRCA2-mutant\", \"class\": \"Mutation\", \"start\": 69, \"end\": 81, \"ids\": []},\n        {\"text\": \"PDAC\", \"class\": \"Disease\", \"start\": 82, \"end\": 86, \"ids\": []},\n        {\"text\": \"resistance\", \"class\": \"Phenotype\", \"start\": 153, \"end\": 163, \"ids\": []}\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 130, "completion_tokens": 6192, "total_tokens": 6322, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 5952, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40874518", "sentence_id": 2, "text": "Our objective is to investigate mechanisms of resistance to PARPi in BRCA2-mutant PDAC cells and identify potential therapeutic targets to modulate this resistance."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40874518\", \"sentence_id\": 3, \"text\": \"We developed olaparib- and talazoparib-resistant Capan-1 cell lines and characterised their resistance profiles using viability assays, RNA sequencing and metabolomic profiling.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDn7Nk2bSXJOPsylDAr6pbZcnF", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40874518\",\n      \"sentence_id\": 3,\n      \"entities\": [\n        {\n          \"text\": \"olaparib\",\n          \"class\": \"Chemical\",\n          \"start\": 13,\n          \"end\": 21,\n          \"ids\": []\n        },\n        {\n          \"text\": \"talazoparib\",\n          \"class\": \"Chemical\",\n          \"start\": 27,\n          \"end\": 38,\n          \"ids\": []\n        },\n        {\n          \"text\": \"Capan-1\",\n          \"class\": \"Model\",\n          \"start\": 49,\n          \"end\": 56,\n          \"ids\": []\n        },\n        {\n          \"text\": \"resistance\",\n          \"class\": \"Phenotype\",\n          \"start\": 92,\n          \"end\": 102,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 134, "completion_tokens": 5201, "total_tokens": 5335, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 4992, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40874518", "sentence_id": 3, "text": "We developed olaparib- and talazoparib-resistant Capan-1 cell lines and characterised their resistance profiles using viability assays, RNA sequencing and metabolomic profiling."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41173779\", \"sentence_id\": 12, \"text\": \"CONCLUSIONS AND CLINICAL IMPLICATIONS: In men with mCRPC, high gLOH status was associated with enhanced responses to talazoparib.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDqCNzil5QH3Ebym4UN8at26L3", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41173779\",\n      \"sentence_id\": 12,\n      \"entities\": [\n        {\n          \"text\": \"mCRPC\",\n          \"class\": \"Disease\",\n          \"start\": 42,\n          \"end\": 47,\n          \"ids\": []\n        },\n        {\n          \"text\": \"gLOH\",\n          \"class\": \"Phenotype\",\n          \"start\": 54,\n          \"end\": 58,\n          \"ids\": []\n        },\n        {\n          \"text\": \"talazoparib\",\n          \"class\": \"Chemical\",\n          \"start\": 108,\n          \"end\": 119,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 134, "completion_tokens": 4903, "total_tokens": 5037, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 4736, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41173779", "sentence_id": 12, "text": "CONCLUSIONS AND CLINICAL IMPLICATIONS: In men with mCRPC, high gLOH status was associated with enhanced responses to talazoparib."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 6, \"text\": \"and Chinese payers, total costs, quality-adjusted life years (QALYs), and incremental cost-effectiveness ratios (ICER) were considered as the primary outputs in the model.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDpXVpdaameHqTHtJ2Qz5Cm6qs", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40873813\",\n      \"sentence_id\": 6,\n      \"entities\": [\n        {\n          \"text\": \"total costs\",\n          \"class\": \"Finding\",\n          \"start\": 20,\n          \"end\": 31,\n          \"ids\": []\n        },\n        {\n          \"text\": \"QALYs\",\n          \"class\": \"Phenotype\",\n          \"start\": 62,\n          \"end\": 67,\n          \"ids\": []\n        },\n        {\n          \"text\": \"ICER\",\n          \"class\": \"Finding\",\n          \"start\": 109,\n          \"end\": 113,\n          \"ids\": []\n        },\n        {\n          \"text\": \"model\",\n          \"class\": \"Model\",\n          \"start\": 161,\n          \"end\": 166,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 137, "completion_tokens": 5004, "total_tokens": 5141, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 4800, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40873813", "sentence_id": 6, "text": "and Chinese payers, total costs, quality-adjusted life years (QALYs), and incremental cost-effectiveness ratios (ICER) were considered as the primary outputs in the model."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41173779\", \"sentence_id\": 3, \"text\": \"We used tumor and saliva alteration results, and somatic-germline-zygosity prediction to assess genomic alterations.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDhsWYBDPeVSI7g6j5XesO4iS1", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41173779\",\n      \"sentence_id\": 3,\n      \"entities\": [\n        {\n          \"text\": \"tumor\",\n          \"class\": \"Disease\",\n          \"start\": 8,\n          \"end\": 13,\n          \"ids\": []\n        },\n        {\n          \"text\": \"alteration\",\n          \"class\": \"Finding\",\n          \"start\": 25,\n          \"end\": 35,\n          \"ids\": []\n        },\n        {\n          \"text\": \"somatic-germline-zygosity\",\n          \"class\": \"Phenotype\",\n          \"start\": 49,\n          \"end\": 74,\n          \"ids\": []\n        },\n        {\n          \"text\": \"genomic alterations\",\n          \"class\": \"Mutation\",\n          \"start\": 96,\n          \"end\": 115,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 123, "completion_tokens": 5200, "total_tokens": 5323, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 4992, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41173779", "sentence_id": 3, "text": "We used tumor and saliva alteration results, and somatic-germline-zygosity prediction to assess genomic alterations."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41173779\", \"sentence_id\": 8, \"text\": \"In tumors bearing ATM alterations, ORR was greater in those with (two of four) versus without PTEN alterations (zero of 13; p\u00a0=\u00a00.044).\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDbK7gOvcJznsDFR5jIwrqgkld", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41173779\",\n      \"sentence_id\": 8,\n      \"entities\": [\n        {\n          \"text\": \"ATM\",\n          \"class\": \"Gene\",\n          \"start\": 18,\n          \"end\": 21,\n          \"ids\": []\n        },\n        {\n          \"text\": \"ATM alterations\",\n          \"class\": \"Mutation\",\n          \"start\": 18,\n          \"end\": 33,\n          \"ids\": []\n        },\n        {\n          \"text\": \"PTEN\",\n          \"class\": \"Gene\",\n          \"start\": 94,\n          \"end\": 98,\n          \"ids\": []\n        },\n        {\n          \"text\": \"ORR\",\n          \"class\": \"Finding\",\n          \"start\": 35,\n          \"end\": 38,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 137, "completion_tokens": 5898, "total_tokens": 6035, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 5696, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41173779", "sentence_id": 8, "text": "In tumors bearing ATM alterations, ORR was greater in those with (two of four) versus without PTEN alterations (zero of 13; p\u00a0=\u00a00.044)."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683290\", \"sentence_id\": 9, \"text\": \"Safety was assessed in patients who received at least one dose of a study drug.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8Ndwow0CRQU64KQFOEvUYooHR0V", "object": "chat.completion", "created": 1763443041, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40683290\",\n      \"sentence_id\": 9,\n      \"entities\": [\n        {\n          \"text\": \"Safety\",\n          \"class\": \"Finding\",\n          \"start\": 0,\n          \"end\": 6,\n          \"ids\": []\n        },\n        {\n          \"text\": \"study drug\",\n          \"class\": \"Chemical\",\n          \"start\": 68,\n          \"end\": 78,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 115, "completion_tokens": 2683, "total_tokens": 2798, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 2560, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40683290", "sentence_id": 9, "text": "Safety was assessed in patients who received at least one dose of a study drug."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41186828\", \"sentence_id\": 8, \"text\": \"However, this combination did not exert synergism in TNBC cells despite a higher apoptotic rate and increased DNA damage compared with the drug alone.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDOaG2Ey4Fnqg79AVQhU9M4zyC", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41186828\",\n      \"sentence_id\": 8,\n      \"entities\": [\n        {\"text\": \"synergism\", \"class\": \"Finding\", \"start\": 40, \"end\": 49, \"ids\": []},\n        {\"text\": \"TNBC\", \"class\": \"Disease\", \"start\": 53, \"end\": 57, \"ids\": []},\n        {\"text\": \"apoptotic rate\", \"class\": \"Phenotype\", \"start\": 81, \"end\": 95, \"ids\": []},\n        {\"text\": \"DNA damage\", \"class\": \"Phenotype\", \"start\": 110, \"end\": 120, \"ids\": []}\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 128, "completion_tokens": 5041, "total_tokens": 5169, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 4864, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41186828", "sentence_id": 8, "text": "However, this combination did not exert synergism in TNBC cells despite a higher apoptotic rate and increased DNA damage compared with the drug alone."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41077155\", \"sentence_id\": 0, \"text\": \"P-glycoprotein (Pgp), a membrane-bound transporter protein, plays significant roles in the development of multidrug resistance (MDR) and in drug disposition.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDLFIqDM9aVCrxfPRMirTsJixe", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41077155\",\n      \"sentence_id\": 0,\n      \"entities\": [\n        {\n          \"text\": \"P-glycoprotein\",\n          \"class\": \"Gene\",\n          \"start\": 0,\n          \"end\": 14,\n          \"ids\": []\n        },\n        {\n          \"text\": \"Pgp\",\n          \"class\": \"Gene\",\n          \"start\": 16,\n          \"end\": 19,\n          \"ids\": []\n        },\n        {\n          \"text\": \"multidrug resistance\",\n          \"class\": \"Phenotype\",\n          \"start\": 106,\n          \"end\": 126,\n          \"ids\": []\n        },\n        {\n          \"text\": \"MDR\",\n          \"class\": \"Phenotype\",\n          \"start\": 128,\n          \"end\": 131,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 134, "completion_tokens": 5904, "total_tokens": 6038, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 5696, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41077155", "sentence_id": 0, "text": "P-glycoprotein (Pgp), a membrane-bound transporter protein, plays significant roles in the development of multidrug resistance (MDR) and in drug disposition."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41049440\", \"sentence_id\": 0, \"text\": \"Glioblastoma multiforme (GBM) is characterized by rapid progression, therapeutic resistance, and a profoundly immunosuppressive tumor microenvironment.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDrwBCXYU8Php2I76iVgUxS9eD", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41049440\",\n      \"sentence_id\": 0,\n      \"entities\": [\n        {\n          \"text\": \"Glioblastoma multiforme\",\n          \"class\": \"Disease\",\n          \"start\": 0,\n          \"end\": 23,\n          \"ids\": []\n        },\n        {\n          \"text\": \"GBM\",\n          \"class\": \"Disease\",\n          \"start\": 25,\n          \"end\": 28,\n          \"ids\": []\n        },\n        {\n          \"text\": \"rapid progression\",\n          \"class\": \"Phenotype\",\n          \"start\": 50,\n          \"end\": 67,\n          \"ids\": []\n        },\n        {\n          \"text\": \"therapeutic resistance\",\n          \"class\": \"Phenotype\",\n          \"start\": 69,\n          \"end\": 91,\n          \"ids\": []\n        },\n        {\n          \"text\": \"immunosuppressive tumor microenvironment\",\n          \"class\": \"Phenotype\",\n          \"start\": 111,\n          \"end\": 149,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 129, "completion_tokens": 6206, "total_tokens": 6335, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 5952, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41049440", "sentence_id": 0, "text": "Glioblastoma multiforme (GBM) is characterized by rapid progression, therapeutic resistance, and a profoundly immunosuppressive tumor microenvironment."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683290\", \"sentence_id\": 6, \"text\": \"The sponsor, patients, and investigators were masked to talazoparib or placebo, and enzalutamide was open label.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NctwbVPggxuaubhACQtYORnYs8", "object": "chat.completion", "created": 1763443040, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40683290\",\n      \"sentence_id\": 6,\n      \"entities\": [\n        {\n          \"text\": \"talazoparib\",\n          \"class\": \"Chemical\",\n          \"start\": 55,\n          \"end\": 66,\n          \"ids\": []\n        },\n        {\n          \"text\": \"placebo\",\n          \"class\": \"Chemical\",\n          \"start\": 70,\n          \"end\": 77,\n          \"ids\": []\n        },\n        {\n          \"text\": \"enzalutamide\",\n          \"class\": \"Chemical\",\n          \"start\": 83,\n          \"end\": 95,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 126, "completion_tokens": 3111, "total_tokens": 3237, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 2944, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40683290", "sentence_id": 6, "text": "The sponsor, patients, and investigators were masked to talazoparib or placebo, and enzalutamide was open label."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683290\", \"sentence_id\": 7, \"text\": \"The primary endpoint was rPFS by blinded independent central review, and overall survival (time from randomisation to death due to any cause) was an event-based \u03b1-protected key secondary endpoint (\u03b1-threshold at final overall survival analysis was 0\u00b7022 [two-sided])-both assessed in the intention-to-treat population.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NcB8hOS3QInZOXNXgYlEQ3ZPSn", "object": "chat.completion", "created": 1763443040, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40683290\",\n      \"sentence_id\": 7,\n      \"entities\": [\n        {\n          \"text\": \"rPFS\",\n          \"class\": \"Finding\",\n          \"start\": 25,\n          \"end\": 29,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 165, "completion_tokens": 4632, "total_tokens": 4797, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 4544, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40683290", "sentence_id": 7, "text": "The primary endpoint was rPFS by blinded independent central review, and overall survival (time from randomisation to death due to any cause) was an event-based \u03b1-protected key secondary endpoint (\u03b1-threshold at final overall survival analysis was 0\u00b7022 [two-sided])-both assessed in the intention-to-treat population."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41049440\", \"sentence_id\": 4, \"text\": \"The MetaCore pathway and Gene Set Enrichment Analysis (GSEA) identified ORMDL2's involvement in antigen presentation via a major histocompatibility complex I (MHC class I), unfolded protein response (UPR), and mitochondrial apoptotic signaling.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDGzInXTLnPn929vNcuUkCyC9U", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41049440\",\n      \"sentence_id\": 4,\n      \"entities\": [\n        {\"text\": \"MetaCore pathway\", \"class\": \"Pathway\", \"start\": 4, \"end\": 19, \"ids\": []},\n        {\"text\": \"Gene Set Enrichment Analysis (GSEA)\", \"class\": \"Finding\", \"start\": 25, \"end\": 59, \"ids\": []},\n        {\"text\": \"ORMDL2\", \"class\": \"Gene\", \"start\": 72, \"end\": 77, \"ids\": []},\n        {\"text\": \"antigen presentation\", \"class\": \"Phenotype\", \"start\": 96, \"end\": 115, \"ids\": []},\n        {\"text\": \"MHC class I\", \"class\": \"Phenotype\", \"start\": 151, \"end\": 161, \"ids\": []},\n        {\"text\": \"unfolded protein response\", \"class\": \"Pathway\", \"start\": 165, \"end\": 189, \"ids\": []},\n        {\"text\": \"UPR\", \"class\": \"Pathway\", \"start\": 192, \"end\": 194, \"ids\": []},\n        {\"text\": \"mitochondrial apoptotic signaling\", \"class\": \"Pathway\", \"start\": 202, \"end\": 234, \"ids\": []}\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 151, "completion_tokens": 6531, "total_tokens": 6682, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 6208, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41049440", "sentence_id": 4, "text": "The MetaCore pathway and Gene Set Enrichment Analysis (GSEA) identified ORMDL2's involvement in antigen presentation via a major histocompatibility complex I (MHC class I), unfolded protein response (UPR), and mitochondrial apoptotic signaling."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683287\", \"sentence_id\": 7, \"text\": \"The sponsor, patients, and investigators were masked to talazoparib or placebo, whereas enzalutamide was open label.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8Nig7SmCE4V7iewzbMGBJ29YpYf", "object": "chat.completion", "created": 1763443046, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40683287\",\n      \"sentence_id\": 7,\n      \"entities\": [\n        {\n          \"text\": \"talazoparib\",\n          \"class\": \"Chemical\",\n          \"start\": 56,\n          \"end\": 66,\n          \"ids\": []\n        },\n        {\n          \"text\": \"placebo\",\n          \"class\": \"Chemical\",\n          \"start\": 71,\n          \"end\": 77,\n          \"ids\": []\n        },\n        {\n          \"text\": \"enzalutamide\",\n          \"class\": \"Chemical\",\n          \"start\": 88,\n          \"end\": 99,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 126, "completion_tokens": 2535, "total_tokens": 2661, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 2368, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40683287", "sentence_id": 7, "text": "The sponsor, patients, and investigators were masked to talazoparib or placebo, whereas enzalutamide was open label."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683287\", \"sentence_id\": 9, \"text\": \"Follow-up for overall survival was intended to continue until the planned final analysis.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NljDOKiw6ptfmu0TMorYm3dP13", "object": "chat.completion", "created": 1763443049, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40683287\",\n      \"sentence_id\": 9,\n      \"entities\": [\n        {\n          \"text\": \"overall survival\",\n          \"class\": \"Finding\",\n          \"start\": 14,\n          \"end\": 29,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 114, "completion_tokens": 2517, "total_tokens": 2631, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 2432, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40683287", "sentence_id": 9, "text": "Follow-up for overall survival was intended to continue until the planned final analysis."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40661990\", \"sentence_id\": 6, \"text\": \"Sensitivity analyses were performed to examine the robustness of model results.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NrjvRKo3c9xBJLLTVK7HLHhVn0", "object": "chat.completion", "created": 1763443055, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40661990\",\n      \"sentence_id\": 6,\n      \"entities\": [\n        {\n          \"text\": \"model\",\n          \"class\": \"Model\",\n          \"start\": 65,\n          \"end\": 70,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 111, "completion_tokens": 1620, "total_tokens": 1731, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 1536, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40661990", "sentence_id": 6, "text": "Sensitivity analyses were performed to examine the robustness of model results."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41186828\", \"sentence_id\": 2, \"text\": \"Ataxia telangiectasia and Rad3-related (ATR) regulates genome integrity, and thus, the aberrant activation of ATR could play a significant role in the pathogenesis of TNBC and be associated with PARPi resistance in especially homologous recombinant deficiency tumors.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDPFSsyBF2XGKem8xIYWULcR89", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41186828\",\n      \"sentence_id\": 2,\n      \"entities\": [\n        {\"text\": \"ATR\", \"class\": \"Gene\", \"start\": 40, \"end\": 43, \"ids\": []},\n        {\"text\": \"ATR\", \"class\": \"Gene\", \"start\": 107, \"end\": 110, \"ids\": []},\n        {\"text\": \"TNBC\", \"class\": \"Disease\", \"start\": 163, \"end\": 167, \"ids\": []},\n        {\"text\": \"PARPi\", \"class\": \"Chemical\", \"start\": 189, \"end\": 194, \"ids\": []},\n        {\"text\": \"deficiency\", \"class\": \"Phenotype\", \"start\": 242, \"end\": 252, \"ids\": []}\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 153, "completion_tokens": 6539, "total_tokens": 6692, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 6336, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41186828", "sentence_id": 2, "text": "Ataxia telangiectasia and Rad3-related (ATR) regulates genome integrity, and thus, the aberrant activation of ATR could play a significant role in the pathogenesis of TNBC and be associated with PARPi resistance in especially homologous recombinant deficiency tumors."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41049440\", \"sentence_id\": 6, \"text\": \"Pharmacogenomic correlation via the Genomics in Drug Sensitivity in Cancer (GDSC) and Cancer Therapeutics Response Portal (CTRP) database suggested that ORMDL2 expression was associated with resistance to DNA damage response inhibitors such as etoposide, doxorubicin, talazoparib, and might interact with sphingolipid-targeting compounds.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDKBdbRB0BXn4ZRCr2DAfB2hXG", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41049440\",\n      \"sentence_id\": 6,\n      \"entities\": [\n        {\n          \"text\": \"GDSC\",\n          \"class\": \"Model\",\n          \"start\": 76,\n          \"end\": 80,\n          \"ids\": []\n        },\n        {\n          \"text\": \"CTRP\",\n          \"class\": \"Model\",\n          \"start\": 123,\n          \"end\": 127,\n          \"ids\": []\n        },\n        {\n          \"text\": \"ORMDL2\",\n          \"class\": \"Gene\",\n          \"start\": 153,\n          \"end\": 159,\n          \"ids\": []\n        },\n        {\n          \"text\": \"etoposide\",\n          \"class\": \"Chemical\",\n          \"start\": 244,\n          \"end\": 253,\n          \"ids\": []\n        },\n        {\n          \"text\": \"doxorubicin\",\n          \"class\": \"Chemical\",\n          \"start\": 255,\n          \"end\": 266,\n          \"ids\": []\n        },\n        {\n          \"text\": \"talazoparib\",\n          \"class\": \"Chemical\",\n          \"start\": 268,\n          \"end\": 279,\n          \"ids\": []\n        },\n        {\n          \"text\": \"sphingolipid-targeting compounds\",\n          \"class\": \"Chemical\",\n          \"start\": 305,\n          \"end\": 337,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 176, "completion_tokens": 6538, "total_tokens": 6714, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 6208, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41049440", "sentence_id": 6, "text": "Pharmacogenomic correlation via the Genomics in Drug Sensitivity in Cancer (GDSC) and Cancer Therapeutics Response Portal (CTRP) database suggested that ORMDL2 expression was associated with resistance to DNA damage response inhibitors such as etoposide, doxorubicin, talazoparib, and might interact with sphingolipid-targeting compounds."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41219112\", \"sentence_id\": 6, \"text\": \"However, response to PARPi seems to vary depending on the genes altered, with a greater benefit for patients with mutations in genes encoding the repair effector proteins BRCA1/2, CDK12, and PALB2.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDvGSUH1TlIwzo1A7uxJpMKsFE", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41219112\",\n      \"sentence_id\": 6,\n      \"entities\": [\n        {\n          \"text\": \"PARPi\",\n          \"class\": \"Chemical\",\n          \"start\": 21,\n          \"end\": 26,\n          \"ids\": []\n        },\n        {\n          \"text\": \"mutations\",\n          \"class\": \"Mutation\",\n          \"start\": 114,\n          \"end\": 123,\n          \"ids\": []\n        },\n        {\n          \"text\": \"BRCA1/2\",\n          \"class\": \"Gene\",\n          \"start\": 171,\n          \"end\": 178,\n          \"ids\": []\n        },\n        {\n          \"text\": \"CDK12\",\n          \"class\": \"Gene\",\n          \"start\": 180,\n          \"end\": 185,\n          \"ids\": []\n        },\n        {\n          \"text\": \"PALB2\",\n          \"class\": \"Gene\",\n          \"start\": 191,\n          \"end\": 196,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 145, "completion_tokens": 6963, "total_tokens": 7108, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 6720, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41219112", "sentence_id": 6, "text": "However, response to PARPi seems to vary depending on the genes altered, with a greater benefit for patients with mutations in genes encoding the repair effector proteins BRCA1/2, CDK12, and PALB2."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40873813\", \"sentence_id\": 0, \"text\": \"BACKGROUND: The phase III TALAPRO-2 trial established that combining talazoparib (TALA) with enzalutamide significantly extends progression-free survival (PFS) and overall survival in metastatic castration-resistant prostate cancer (mCRPC) patients.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDJOOssTVNQeWRn7GrGXnF5NNG", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40873813\",\n      \"sentence_id\": 0,\n      \"entities\": [\n        {\n          \"text\": \"talazoparib\",\n          \"class\": \"Chemical\",\n          \"start\": 69,\n          \"end\": 79,\n          \"ids\": []\n        },\n        {\n          \"text\": \"enzalutamide\",\n          \"class\": \"Chemical\",\n          \"start\": 93,\n          \"end\": 104,\n          \"ids\": []\n        },\n        {\n          \"text\": \"progression-free survival\",\n          \"class\": \"Finding\",\n          \"start\": 128,\n          \"end\": 150,\n          \"ids\": []\n        },\n        {\n          \"text\": \"PFS\",\n          \"class\": \"Finding\",\n          \"start\": 153,\n          \"end\": 155,\n          \"ids\": []\n        },\n        {\n          \"text\": \"overall survival\",\n          \"class\": \"Finding\",\n          \"start\": 162,\n          \"end\": 176,\n          \"ids\": []\n        },\n        {\n          \"text\": \"metastatic castration-resistant prostate cancer\",\n          \"class\": \"Disease\",\n          \"start\": 181,\n          \"end\": 228,\n          \"ids\": []\n        },\n        {\n          \"text\": \"mCRPC\",\n          \"class\": \"Disease\",\n          \"start\": 231,\n          \"end\": 235,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 153, "completion_tokens": 6728, "total_tokens": 6881, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 6400, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40873813", "sentence_id": 0, "text": "BACKGROUND: The phase III TALAPRO-2 trial established that combining talazoparib (TALA) with enzalutamide significantly extends progression-free survival (PFS) and overall survival in metastatic castration-resistant prostate cancer (mCRPC) patients."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40954422\", \"sentence_id\": 4, \"text\": \"We discuss the importance of testing for HRR gene alterations in mCRPC, appropriate dosing and administration, and our clinical experiences of adverse event monitoring and dose modifications as illustrative examples of the role of oncology nurses and APPs in the treatment of mCRPC with talazoparib plus enzalutamide.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDOEQsdi1Pe2t1NMWTmfR2NBgk", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40954422\",\n      \"sentence_id\": 4,\n      \"entities\": [\n        {\n          \"text\": \"HRR gene alterations\",\n          \"class\": \"Mutation\",\n          \"start\": 41,\n          \"end\": 61,\n          \"ids\": []\n        },\n        {\n          \"text\": \"mCRPC\",\n          \"class\": \"Disease\",\n          \"start\": 65,\n          \"end\": 70,\n          \"ids\": []\n        },\n        {\n          \"text\": \"adverse event monitoring\",\n          \"class\": \"Finding\",\n          \"start\": 143,\n          \"end\": 167,\n          \"ids\": []\n        },\n        {\n          \"text\": \"dose modifications\",\n          \"class\": \"Finding\",\n          \"start\": 172,\n          \"end\": 190,\n          \"ids\": []\n        },\n        {\n          \"text\": \"mCRPC\",\n          \"class\": \"Disease\",\n          \"start\": 276,\n          \"end\": 281,\n          \"ids\": []\n        },\n        {\n          \"text\": \"talazoparib\",\n          \"class\": \"Chemical\",\n          \"start\": 286,\n          \"end\": 297,\n          \"ids\": []\n        },\n        {\n          \"text\": \"enzalutamide\",\n          \"class\": \"Chemical\",\n          \"start\": 303,\n          \"end\": 314,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 162, "completion_tokens": 6664, "total_tokens": 6826, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 6336, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40954422", "sentence_id": 4, "text": "We discuss the importance of testing for HRR gene alterations in mCRPC, appropriate dosing and administration, and our clinical experiences of adverse event monitoring and dose modifications as illustrative examples of the role of oncology nurses and APPs in the treatment of mCRPC with talazoparib plus enzalutamide."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40498229\", \"sentence_id\": 0, \"text\": \"PARP1, the most prominent member of the PARP family, mediates DNA repair and cellular stress responses.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NwFpRdg12nelpT6oAFMNcT09bR", "object": "chat.completion", "created": 1763443060, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40498229\",\n      \"sentence_id\": 0,\n      \"entities\": [\n        {\n          \"text\": \"PARP1\",\n          \"class\": \"Gene\",\n          \"start\": 0,\n          \"end\": 5,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 122, "completion_tokens": 1302, "total_tokens": 1424, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 1216, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40498229", "sentence_id": 0, "text": "PARP1, the most prominent member of the PARP family, mediates DNA repair and cellular stress responses."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41186828\", \"sentence_id\": 7, \"text\": \"The overexpression of ATR and associated cell cycle proteins could play a role in PARPi resistance.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8ND7fGnbWNRcm8ybXc1Zwe3MSEF", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41186828\",\n      \"sentence_id\": 7,\n      \"entities\": [\n        {\n          \"text\": \"ATR\",\n          \"class\": \"Gene\",\n          \"start\": 22,\n          \"end\": 25,\n          \"ids\": []\n        },\n        {\n          \"text\": \"cell cycle\",\n          \"class\": \"Pathway\",\n          \"start\": 41,\n          \"end\": 51,\n          \"ids\": [\"KEGG:hsa04110\"]\n        },\n        {\n          \"text\": \"PARPi\",\n          \"class\": \"Chemical\",\n          \"start\": 82,\n          \"end\": 87,\n          \"ids\": []\n        },\n        {\n          \"text\": \"resistance\",\n          \"class\": \"Phenotype\",\n          \"start\": 88,\n          \"end\": 98,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 118, "completion_tokens": 5840, "total_tokens": 5958, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 5632, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41186828", "sentence_id": 7, "text": "The overexpression of ATR and associated cell cycle proteins could play a role in PARPi resistance."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41173779\", \"sentence_id\": 6, \"text\": \"Commonly altered non-DDR-HRR genes included TMPRSS2, TP53, PTEN, androgen receptor (AR), MYC, and SPOP.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDc0DrnAugys2iefXAPt0VwRHd", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41173779\",\n      \"sentence_id\": 6,\n      \"entities\": [\n        {\"text\": \"TMPRSS2\", \"class\": \"Gene\", \"start\": 44, \"end\": 50, \"ids\": []},\n        {\"text\": \"TP53\", \"class\": \"Gene\", \"start\": 53, \"end\": 56, \"ids\": []},\n        {\"text\": \"PTEN\", \"class\": \"Gene\", \"start\": 59, \"end\": 62, \"ids\": []},\n        {\"text\": \"androgen receptor\", \"class\": \"Gene\", \"start\": 65, \"end\": 81, \"ids\": []},\n        {\"text\": \"MYC\", \"class\": \"Gene\", \"start\": 89, \"end\": 91, \"ids\": []},\n        {\"text\": \"SPOP\", \"class\": \"Gene\", \"start\": 98, \"end\": 101, \"ids\": []}\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 132, "completion_tokens": 5933, "total_tokens": 6065, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 5696, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41173779", "sentence_id": 6, "text": "Commonly altered non-DDR-HRR genes included TMPRSS2, TP53, PTEN, androgen receptor (AR), MYC, and SPOP."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40906325\", \"sentence_id\": 3, \"text\": \"Phase 2 used a composite endpoint of overall response per RECIST v1.1, 50% decline in prostate-specific antigen (PSA), and/or circulating tumor cells (CTC) conversion from\u2009\u2265\u20091 cell/7.5\u00a0mL to 0.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8ND2KyLTVMT6W5HchFc9SyJjl5a", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40906325\",\n      \"sentence_id\": 3,\n      \"entities\": [\n        {\n          \"text\": \"overall response per RECIST v1.1\",\n          \"class\": \"Finding\",\n          \"start\": 34,\n          \"end\": 68,\n          \"ids\": []\n        },\n        {\n          \"text\": \"50% decline in prostate-specific antigen (PSA)\",\n          \"class\": \"Finding\",\n          \"start\": 70,\n          \"end\": 107,\n          \"ids\": []\n        },\n        {\n          \"text\": \"circulating tumor cells (CTC) conversion from \u2265 1 cell/7.5 mL to 0\",\n          \"class\": \"Finding\",\n          \"start\": 116,\n          \"end\": 182,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 156, "completion_tokens": 5960, "total_tokens": 6116, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 5760, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40906325", "sentence_id": 3, "text": "Phase 2 used a composite endpoint of overall response per RECIST v1.1, 50% decline in prostate-specific antigen (PSA), and/or circulating tumor cells (CTC) conversion from\u2009\u2265\u20091 cell/7.5\u00a0mL to 0."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41049440\", \"sentence_id\": 3, \"text\": \"Transcriptomic analyses across The Cancer Genome Atlas (TCGA), and Chinese Glioma Genome Atlas (CGGA) revealed elevated ORMDL2 expression in GBM tissues which causes poor prognosis.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDAbHKvuLcY8AS9c5LezKPfgFM", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41049440\",\n      \"sentence_id\": 3,\n      \"entities\": [\n        {\n          \"text\": \"The Cancer Genome Atlas (TCGA)\",\n          \"class\": \"Model\",\n          \"start\": 31,\n          \"end\": 61,\n          \"ids\": [\"TCGA\"]\n        },\n        {\n          \"text\": \"Chinese Glioma Genome Atlas (CGGA)\",\n          \"class\": \"Model\",\n          \"start\": 67,\n          \"end\": 101,\n          \"ids\": [\"CGGA\"]\n        },\n        {\n          \"text\": \"ORMDL2\",\n          \"class\": \"Gene\",\n          \"start\": 120,\n          \"end\": 126,\n          \"ids\": []\n        },\n        {\n          \"text\": \"GBM\",\n          \"class\": \"Disease\",\n          \"start\": 141,\n          \"end\": 144,\n          \"ids\": []\n        },\n        {\n          \"text\": \"prognosis\",\n          \"class\": \"Finding\",\n          \"start\": 171,\n          \"end\": 180,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 137, "completion_tokens": 6854, "total_tokens": 6991, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 6592, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41049440", "sentence_id": 3, "text": "Transcriptomic analyses across The Cancer Genome Atlas (TCGA), and Chinese Glioma Genome Atlas (CGGA) revealed elevated ORMDL2 expression in GBM tissues which causes poor prognosis."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40848312\", \"sentence_id\": 1, \"text\": \"Genomic analysis identified alterations in DNA damage repair (DDR) pathways, in up to 30% of metastatic castration-resistant prostate cancer (mCRPC).\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NTyds9SVaxsJYNOoICcpu5gMEc", "object": "chat.completion", "created": 1763443031, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40848312\",\n      \"sentence_id\": 1,\n      \"entities\": [\n        {\n          \"text\": \"Genomic analysis\",\n          \"class\": \"Finding\",\n          \"start\": 0,\n          \"end\": 16,\n          \"ids\": []\n        },\n        {\n          \"text\": \"DNA damage repair (DDR) pathways\",\n          \"class\": \"Pathway\",\n          \"start\": 43,\n          \"end\": 75,\n          \"ids\": []\n        },\n        {\n          \"text\": \"metastatic castration-resistant prostate cancer\",\n          \"class\": \"Disease\",\n          \"start\": 93,\n          \"end\": 140,\n          \"ids\": []\n        },\n        {\n          \"text\": \"mCRPC\",\n          \"class\": \"Disease\",\n          \"start\": 142,\n          \"end\": 147,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 132, "completion_tokens": 4887, "total_tokens": 5019, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 4672, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40848312", "sentence_id": 1, "text": "Genomic analysis identified alterations in DNA damage repair (DDR) pathways, in up to 30% of metastatic castration-resistant prostate cancer (mCRPC)."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"40683287\", \"sentence_id\": 11, \"text\": \"Safety was assessed in patients who had received at least one study drug dose.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8Nly3oOn3NLrI9t60QnbVz78iOM", "object": "chat.completion", "created": 1763443049, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"40683287\",\n      \"sentence_id\": 11,\n      \"entities\": [\n        {\n          \"text\": \"Safety\",\n          \"class\": \"Finding\",\n          \"start\": 0,\n          \"end\": 6,\n          \"ids\": []\n        },\n        {\n          \"text\": \"study drug\",\n          \"class\": \"Chemical\",\n          \"start\": 62,\n          \"end\": 72,\n          \"ids\": []\n        }\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 114, "completion_tokens": 2682, "total_tokens": 2796, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 2560, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "40683287", "sentence_id": 11, "text": "Safety was assessed in patients who had received at least one study drug dose."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41219112\", \"sentence_id\": 4, \"text\": \"KEY FINDINGS AND LIMITATIONS: Phase 3 studies evaluating the efficacy of PARPi agents available (olaparib, niraparib, rucaparib, and talazoparib) for the treatment of metastatic CRPC have confirmed their ability to prolong OS, especially in patients carrying BRCA1/2 mutations.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDQByFnFOgoLKJmOERmaRazrnH", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41219112\",\n      \"sentence_id\": 4,\n      \"entities\": [\n        {\"text\": \"PARPi\", \"class\": \"Chemical\", \"start\": 73, \"end\": 77, \"ids\": []},\n        {\"text\": \"olaparib\", \"class\": \"Chemical\", \"start\": 97, \"end\": 104, \"ids\": []},\n        {\"text\": \"niraparib\", \"class\": \"Chemical\", \"start\": 107, \"end\": 115, \"ids\": []},\n        {\"text\": \"rucaparib\", \"class\": \"Chemical\", \"start\": 118, \"end\": 126, \"ids\": []},\n        {\"text\": \"talazoparib\", \"class\": \"Chemical\", \"start\": 133, \"end\": 143, \"ids\": []},\n        {\"text\": \"metastatic CRPC\", \"class\": \"Disease\", \"start\": 167, \"end\": 181, \"ids\": []},\n        {\"text\": \"OS\", \"class\": \"Finding\", \"start\": 223, \"end\": 224, \"ids\": []},\n        {\"text\": \"BRCA1/2\", \"class\": \"Gene\", \"start\": 259, \"end\": 265, \"ids\": []},\n        {\"text\": \"mutations\", \"class\": \"Mutation\", \"start\": 267, \"end\": 275, \"ids\": []}\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 165, "completion_tokens": 6994, "total_tokens": 7159, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 6656, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41219112", "sentence_id": 4, "text": "KEY FINDINGS AND LIMITATIONS: Phase 3 studies evaluating the efficacy of PARPi agents available (olaparib, niraparib, rucaparib, and talazoparib) for the treatment of metastatic CRPC have confirmed their ability to prolong OS, especially in patients carrying BRCA1/2 mutations."}]
[{"model": "gpt-5-nano-2025-08-07", "messages": [{"role": "system", "content": "You are a biomedical relation extraction assistant."}, {"role": "user", "content": "Identify biomedical entities for each sentence below.\nClasses: Gene, Chemical, Mutation, Disease, Phenotype, Pathway, Model, Finding, Paper.\nReturn JSON with `results`: [{pmid, sentence_id, entities:[{text,class,start,end,ids}]}].\nSentences JSON:\n[{\"pmid\": \"41186828\", \"sentence_id\": 9, \"text\": \"Therefore, the dual targeting of ATR and PARP is a promising modality to reverse PARPi resistance with the downregulation of ATR-Chk1 based DNA damage response.\"}]"}], "response_format": {"type": "json_object"}}, {"id": "chatcmpl-Cd8NDMQZFPvRPpVqJifZLNYCUGhJE", "object": "chat.completion", "created": 1763443015, "model": "gpt-5-nano-2025-08-07", "choices": [{"index": 0, "message": {"role": "assistant", "content": "{\n  \"results\": [\n    {\n      \"pmid\": \"41186828\",\n      \"sentence_id\": 9,\n      \"entities\": [\n        {\"text\": \"ATR\", \"class\": \"Gene\", \"start\": 33, \"end\": 36, \"ids\": []},\n        {\"text\": \"PARP\", \"class\": \"Gene\", \"start\": 41, \"end\": 45, \"ids\": []},\n        {\"text\": \"PARPi\", \"class\": \"Chemical\", \"start\": 81, \"end\": 86, \"ids\": []},\n        {\"text\": \"Chk1\", \"class\": \"Gene\", \"start\": 129, \"end\": 133, \"ids\": []},\n        {\"text\": \"ATR-Chk1\", \"class\": \"Pathway\", \"start\": 125, \"end\": 133, \"ids\": []},\n        {\"text\": \"DNA damage response\", \"class\": \"Pathway\", \"start\": 140, \"end\": 159, \"ids\": []},\n        {\"text\": \"resistance\", \"class\": \"Phenotype\", \"start\": 87, \"end\": 97, \"ids\": []}\n      ]\n    }\n  ]\n}", "refusal": null, "annotations": []}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 133, "completion_tokens": 6348, "total_tokens": 6481, "prompt_tokens_details": {"cached_tokens": 0, "audio_tokens": 0}, "completion_tokens_details": {"reasoning_tokens": 6080, "audio_tokens": 0, "accepted_prediction_tokens": 0, "rejected_prediction_tokens": 0}}, "service_tier": "default", "system_fingerprint": null}, {"pmid": "41186828", "sentence_id": 9, "text": "Therefore, the dual targeting of ATR and PARP is a promising modality to reverse PARPi resistance with the downregulation of ATR-Chk1 based DNA damage response."}]
